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ABSTRACT 
 
 
 
Grigsby, Claude Ph.D., Biomedical Sciences Ph.D. program, Wright State university, 
2013. A Comprehensive Tool and Analytical Pathway for Differential Molecular Profiling  
and Biomarker Discovery 
 
 
 
 The key requirements to any empirically based study are to:  (1) accurately 
measure and then compare the collected results in determining the result of the 
hypothesis being tested; and (2) collect a sample representative of the entities being 
studied.  To demonstrate that an informatics tool can be designed that provides spectral 
registration, spectral and chromatographic alignment, visualization, and comparative 
analysis for data generated from multiple analytical platforms, e.g., LC-MS and GC-MS, 
the results and data analysis of five unique sets of experiments using a suite of novel 
informatics tools are presented.  Comprehensive and reproducible sample collection 
techniques were developed concomitantly with the informatics tool and used in the 
multiple, independent studies for the validation and further development of generated 
software tools and approaches.  Data from a dose-response study examining an organ 
specific environmental toxicant exposure was analyzed using the prototype software 
tool for discovery of LC/MS based metabolomic biomarkers.  This data set served as 
proof of concept in the development and illustration of the novel approach to spectral 
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registration and visualization, and illustrates the rapid multi-sample analysis capability 
of the informatics tool.  A variety of additional studies focused on volatile biomarker 
discovery, i.e., a murine model of infection to select agents, characterization of human 
and murine urine as it ages, human markers of age and ethnicity in axillary odors, and 
characterization of the binding between volatile ligands and murine major urinary 
proteins aided in algorithm and interface development for GC/MS functionality 
implemented in the developed software.  The final phase of this work focused on 
utilization of these analysis tools in combination with novel sampling techniques to 
create an end-to-end discovery pipeline for large-scale small molecule and volatile 
organic compound biomarker and differential profiling studies.  This combination of 
biologically and environmentally focused studies were successfully completed as final 
proof of concept for this work and demonstrate the universal utility of the approach.   
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CHAPTER I.  INTRODUCTION  
 
Overview  
 The key requirements to any empirically based study are to (1) accurately 
measure and then compare the collected results in determining the result of the 
hypothesis being tested, and (2) collect a sample representative of the entities being 
studied.  To address this requirement and its application to large scale analytical studies, 
the research described here sought to develop and utilize a logically designed and 
successfully implemented informatics tool for spectral registration, spectral and 
chromatographic alignment, visualization, and comparative analysis in combination with 
reproducible and comprehensive sample collection techniques. This work incorporated 
multiple, independent studies for the development and validation of generated 
software tools and approaches. To both answer active research needs and aid in the 
development and illustration of the novel visualization and rapid multi-sample analysis 
capability of the tool for discovery of LC/MS based metabolomic biomarkers, use of data 
from a dose-response study examining environmental toxicant exposures is also 
described.  A variety of studies focused on volatile biomarker discovery were analyzed 
to aid in algorithm and interface development for GC/MS analysis.  Experiments 
examined in support of this GC/MS analysis included: a murine model of infection to 
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select agents, characterization of human and murine urine as it ages, human markers of 
age and ethnicity in axillary odors, and characterization of the binding between volatile 
ligands and murine major urinary proteins (MUPs).  The final phase of this work 
demonstrates utilization of the analysis tools and workflow developed in combination 
with both optimized and novel sampling techniques to create an end-to-end discovery 
pipeline for large-scale small molecule and volatile organic compound biomarker and 
differential profiling studies.  A combination of biologically and environmentally focused 
studies were assessed as final proof of concept for this analytical workflow and 
demonstrate the universal utility of the approach.  Successful completion of the pipeline 
have facilitated and allowed the efficient and methodical analysis of multiple, large-
scale small molecule and volatile organic compound based biomarker discovery and 
differential molecular profiling studies. 
 
-Omic Profiling, Sampling Considerations, and Data Analysis Tools 
 A brief overview of the various nuances in systems biology data space, analysis 
strategies, and sample collection considerations is required in order to adequately 
frame development and application of the analytical pipeline for large scale profiling 
studies which will be the focus of this proposal. Although the sciences of genomics and 
proteomics are peripheral to much of this research, detail on all three is described as 
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the analysis approaches utilized for each are applicable to all, including metabolomics 
and volatile profiling. It is worth noting that a rich variety of data analysis and data 
mining software tools exist for genomics and proteomics in both open source format 
and from a myriad of vendors, in sharp contrast to the lack of comparable capability in 
the analysis of small molecule and volatile mass spectrometry-based differential 
profiling studies. It was this lack in availability for small molecule metabolomic and 
volatile informatics which served as the impetus and basis for much of the work 
proposed below.  
 
Gene Expression Profiling 
 The unique gene expression profiles in different cells determine their overall 
functionality and phenotype.  Phenotypic changes in response to perturbations resulting 
from external chemical, biological and physical insults are mediated by and the 
consequence of a concerted change in the expression of a large number of genes.  
Therefore, the global gene expression profile represents a unique signature of a specific 
cell state.  By comparing gene expression profiles under different conditions, changes in 
a gene expression profile may be used for classification and predictive models for a 
variety of physiological and pathological states, as well as an indicator/predictor for the 
host response to various external and internal stimuli or insults.  As has been previously 
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demonstrated, gene expression changes elicited under different conditions are tightly 
regulated and highly distinctive [1-6].  Genomics studies have generated useful data 
highlighting the potential molecular mechanisms involved in many human diseases such 
as cancer, heart disease, chronic inflammatory disease, etc. [1-4], as well as providing 
better insights into the mode of action of different chemical toxicants [5, 6].  The DNA 
microarray is a powerful and versatile tool for global gene expression profiling in 
biomedical research, which can be used without well-defined underlying hypotheses.  It 
is therefore extremely useful in discovery-driven research in that it can provide 
mechanistic insights into various physiological or pathological processes.  The 
expression profiles produced by microarray experiments represent the entire 
transcriptome (or a selected portion of it, dependent on the coverage of the array) of 
the cells or the tissue under a particular condition.   
 Analysis of DNA microarray data for biomarker discovery normally involves 
feature selection and class discovery / class prediction using multivariate statistical 
methods and/or pattern recognition techniques [7-9].  The objective is to identify 
informative genes (i.e. a subset of genes that have undergone significant expression 
changes) for a specific condition, such as the onset of a disease or exposure to a 
chemical toxicant.  Before the data analysis can be completed, the data set has to be 
“preprocessed” [10, 11].  The first step of data preprocessing involves data 
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normalization to compensate for inter-array variations due to technical reasons.  The 
next step is to remove the genes with low-quality signals using statistical methods or 
platform-specific algorithms [12].  This will assure that noise of the assay system can be 
effectively filtered out.  Finally, different data transformation techniques (e.g. log-
transformation, mean-centering, etc) may be applied to facilitate data manipulation in 
subsequent data analysis steps [13]. 
 After the data is preprocessed, an exploratory visualization of the data may be 
performed to examine the general grouping of the samples using an unsupervised 
clustering method (e.g. hierarchical clustering, K-means clustering, self-organizing maps, 
or principal component analysis) [14, 15].  Since these unsupervised methods do not 
depend on any a priori assumption on class repartition, they will provide good 
information regarding the effects of various variables on gene expression profiles, as 
well as the presence of potential confounding factors.  If the variable(s) of interest 
appears to be the most dominant factor governing the gene expression profiles, 
informative genes can readily be identified using traditional statistical methods (i.e. 
student t-test, ANOVA, etc.) [16].  However if confounding factors with strong effects on 
gene expression exist, algorithms developed for DNA microarray analysis (i.e. 
Significance Analysis of Microarrays, Predictive Analysis of Microarray, supervised 
pattern recognition techniques or machine learning algorithms) [17-21] will be needed 
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with appropriate re-sampling techniques for cross-validation [22, 23].  Despite the 
inclusion of the cross-validation step, over-fitting of the model may still occur [24-26], 
which will result in the selection of gene expression changes due to experimental 
artifacts and noises.  Therefore, validation using a fully independent data set should be 
performed to ensure that the features selected are authentic informative genes. 
 Identification of informative genes will allow one to focus on a smaller subset of 
genes with direct relevance to the problem of interest.  For instance, genes that are 
differentially expressed in test groups compared with control groups identified in DNA 
microarray experiments can be further validated by analyzing in more detail and in 
larger numbers of subjects using other technology platforms (i.e. quantitative real-time 
RT-PCR) [27].  After additional testing and validation using computational and 
experimental techniques, genes with the highest predictive power can be identified as 
potential biomarkers for a specific physiological or pathological state. 
 
Proteomic Profiling 
 Proteomics is the large-scale study of proteins, particularly their structures and 
functions.  The proteome in both humans and other higher life forms is orders of 
magnitude more complex than the genome. While the genome is a rather constant 
entity, the proteome differs from cell to cell and is constantly changing through its 
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biochemical interactions with the genome and the environment.  One organism will 
have radically different protein expression in different parts of its body, in different 
stages of its life cycle and under different environmental conditions.  Numerous post 
translational modifications combined with amino acid substitutions have been reported 
for the myriad of proteins coded by the genome.  Discovering these differentially 
expressed protein profiles along with their corresponding post translational 
modifications (PTMs) is a critical step in understanding the molecular mechanisms 
regulating function in both single cells and systemically.  One of the core tasks assigned 
to modern proteomics is the identification of differential biological markers that are 
definitive for various states of organism health (i.e. disease vs. no disease, successful 
treatment vs. unsuccessful treatment).  Because levels of proteins in blood and urine 
can reflect an individual’s state of health or disease, proteomics is especially suitable for 
the identification of biomarkers [28].  The field of proteomics is still in development and 
various approaches for separating and identifying proteins are being validated.  
Additionally, separation and relative quantitation of complex protein mixtures remain 
two of the most challenging aspects of proteomics, as will be discussed briefly below.  
Sample preparation is a critical first step in any protein profiling experiment.  Both the 
source of the sample as well as the subsequent processing steps are greatly dependent 
on the objectives of the study.  Detecting and identifying all of the given proteins or 
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peptides in a complex biological mixture such as serum or tissue media is an extremely 
difficult task due to both the wide dynamic range of protein expression levels (1012 
variance in concentration) and the differing physical characteristics and resultant 
behavior of proteins during the separation process.  In addition, in a mass spectral 
analysis, the ion signal of low concentration analytes can easily become saturated by 
highly abundant proteins, such as albumin, that are present in most raw biofluid 
samples.  This signal suppression compromises the identification of low abundant 
proteins that are typically of highest interest in a biomarker discovery program. Multiple 
commercially available devices are available to assist in the depletion of up to the 20 
most abundant proteins from serum/plasma samples, thereby facilitating detection of 
the less abundant proteins present.  Other sample processing steps typically include a 
combination of the following: solubilization, fractionation, equalization, precipitation, 
desalting, and concentration.  
 Several techniques are currently in wide spread use for proteomic profiling.  
Early mass spectrometry (MS) based biomarker profiling had previously been largely 
focused on the Surface Extraction Laser Desorption/Ionization (SELDI) mass 
spectrometry technology (see [29] for a comprehensive review).  Early publications on 
the success of this approach to detect disease fingerprints in complex samples were 
received with some degree of skepticism and critique given subsequent failed attempts 
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to reproduce the results in addition to some obvious flaws in the protocol design [30].  
The high dimensionality of the data, small sample sizes, lack of rigorous analysis of 
technical and biological expressed.  However, many reports employing SELDI time of 
flight (TOF) MS-based approaches demonstrated success in the early detection of many 
different cancers as well as other diseases [31-39].  2-D gel electrophoresis, despite its 
30 year history [40] and the many improvements that have been made to the 
technology over the years [41-44], is still faced with problems in reproducibility and 
comparability of individually generated gel images.  Even with these challenges, many 
laboratories have successfully used this approach to sort out differential changes in 
complex protein mixtures and are routinely able to resolve over 1000 proteins on a 
single gel, representing an adequate sampling of the expressed phenotype of a specific 
sample.  2-D gel separation of proteins also allows for the easy detection of critical 
posttranslational modifications and when performed on silver-stained gels, 2-D gel 
electrophoresis is highly sensitive, detecting proteins down to the low ng levels.  A new 
approach introduced in the past several years is 2D difference in-gel electrophoresis 
(2D-DIGE), a technique designed to minimize gel-to-gel variations. With 2D-DIGE, 
protein extracts from two different samples are covalently labeled with two different 
fluorescent dyes. The labeled samples are then mixed and subsequently separated on a 
single 2DE gel. The gel is subsequently scanned at different wavelengths revealing 
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visually differentially expressed proteins as well as PTMs.  Another recently emerging 
and powerful approach employs Beckman-Coulter’s Proteome PF 2D system combined 
with proprietary analogs [45-49].  This two dimensional separation of complex mixtures 
is performed using isoelectric focusing (IEF) in the liquid phase (first dimension) 
followed by reverse-phase high pressure liquid chromatography (RP-HPLC) in the second 
dimension.  On-line electro spray ionization (ESI) TOF mass spectrometry (see Figure 1) 
enables detection even in third dimension [48].  The accompanying vendor supplied 
software package generates color-coded protein maps that are easy to interpret and the 
differential display of protein profiles enables clear visual differentiation of two 
samples.  Unfortunately the existing Beckman software suite does not allow for the 
comparison of multiple samples as part of a larger study, requiring integration with 
outside bioinformatics and statistical tools typically relegated to genomic array analysis.        
 To identify the chromatographically or electrophoretically separated proteins 
once they are digested with a suitable enzyme (i.e. trypsin), the resultant peptides are 
subjected to different MS techniques that may or may not include additional on-line 
liquid chromatography such as a strong cation exchange column to separate peptides 
before they enter the mass spectrometer.  
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  [50] 
Figure 1.  ESI LC/MS acquired example of three dimensionality seen in 
chromatographic / mass spectral data  
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The MS techniques used for protein identification can be classified by the type of mass 
spectrometer being utilized (quadrupole, TOF, ion trap, ion cyclotron resonance etc. as 
well as hybrid instruments) as well as by the ionization technique used as a source and 
interface with the HPLC.  Electrospray ionization (ESI) and matrix assisted laser 
desorption ionization (MALDI) are the two major techniques commonly used by 
researches for protein profiling, with nano-spray ionization being basically a nano- or 
reduced volume process of ESI.   Nano-spray offers a higher sensitivity versus ESI due to 
the increased efficiency of ionization [51, 52] and has become the defacto standard for 
LC-MS based proteomics. 
 Other widely used approaches for protein profiling include techniques such as 2 
dimensional liquid chromatography (2-D LC) and capillary electrophoresis [53].  In these 
experiments the complex mixtures of proteins are digested with a suitable enzyme 
(trypsin) followed by two physical separation techniques prior to ionization and MS 
detection.  2-D LC systems typically consist of two columns, the first being a strong 
cation exchange (SCX) column and the second a reversed phase (RP) or C18 column [54-
58].  The peptides are initially loaded onto the SCX column and are gradually eluted onto 
the RP column using increasing salt steps with an aqueous/organic gradient between 
increasing salt concentrations.  This approach has facilitated unambiguous identification 
of up to 1,500 proteins from one sample [59]. 
13 
 
Metabolomic Profiling 
 Metabolomics is a rapidly growing field used to characterize the metabolic 
profile of a specific tissue or biofluid. Metabolic profiling, originally pioneered by Jeremy 
Nicholson, Elaine Holmes, and John Lindon at the Imperial College in London [60] 
utilizing nuclear magnetic resonance (NMR) based analysis, has evolved to become one 
of the most common applications of liquid chromatography mass spectrometry (LC-MS) 
[61-63]. Metabolomics is an attractive approach to the study of time-related 
quantitative multivariate metabolic responses to pathophysiological processes by which 
biological and chemical agents, e.g., drugs, can cause perturbations in the 
concentrations and flux of endogenous metabolites involved in critical cellular pathways 
[64]. Thus, cells respond to toxic insult or other stressors by altering their intra-and/or 
extra-cellular environment in an attempt to maintain a homeostatic intracellular 
environment.   
 This metabolic alteration is expressed as a "fingerprint" of biochemical 
perturbations characteristic of the type and target of a toxic insult or disease process 
[65]. These metabolic alterations are often seen in body fluids as changes in metabolic 
profiles in response to toxicity or disease, as the body attempts to maintain homeostasis 
by eliminating substances from the body. Therefore, because many biofluids can be 
easily obtained either non-invasively (urine) or minimally invasively (blood), they are 
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typically used in metabolomic studies [66]. Additionally, if a significant number of trace 
molecules can be identified and monitored, the overall pattern produced may be more 
consistent and predictive than any single biomarker [67], which would prove of great 
value in the development of deployable devices for testing toxic or infectious exposures.  
Volatile Organic Compound Based Metabolomic Profiling 
 A specific area of study within metabolomics is that focused on the volatile 
metabolites. These volatile organic compound based metabolites, or VOC's, generally 
have a boiling point less than 300°C and contain fewer than 12 carbon atoms[68].  
Clinicians frequently associate peculiar body odors with a disease state and for several 
disorders the odors are distinctive enough to be diagnostic [69, 70].  These odors are 
often composed of “organic volatiles” such as nutrients, metabolic intermediates, waste 
products, environmental contaminants, and other compounds of low molecular mass 
involved in metabolism [68].  The concept of metabolic profiling was summarized by 
Jellum et al. as follows, “it seems reasonable to assume that if one were able to identify 
and determine the concentration of all compounds inside the human body, including 
high molecular weight as well as low molecular weight substances, one would probably 
find that almost every known disease would result in characteristic changes of the 
biochemical composition of the cells and the body fluids” [71].  Metabolic disorders are 
often characterized by the accumulation of a small number of metabolites in body 
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fluids, generally because a deficiency in enzymatic activity blocks the normal 
biochemical pathway [72].  
 In the 1970’s, studies of volatile metabolites in human urine by Zlatkis and 
Liebich [73, 74], composed of nearly 200 samples from adults were analyzed by gas 
chromatography - mass spectrometry (GC-MS) and resulted in the identification of the 
forty constituents listed in Table 1.  The identities of these volatiles were subsequently 
confirmed by comparing both the retention times and mass spectra of the compounds 
with known standards. Key components found in the profiles of normal urines are 
ketones (i.e. 2-butanone, 2-pentanone, and 4-heptanone), dimethyl disulfide, several 
alkyl furans, pyrrol, and carvone. Pyrazines are present in trace quantities.  During a 
subsequent study performed in 1973 and 1980, mouse urine was shown to contain well 
over 100 volatile components [75] similar to those in humans, and an additional study in 
1989 [76] identified the compounds listed in Table 2 in an examination of dominant and 
subordinate male mouse urine.  
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Volatile Constituents in Human Urine 
Diethyl ether (solvent) 2-Heptanone 
3-Methyl-2-butanone 3-Methylcyclopentanone (tent) 
2,3(?)-Dimethylfuran Limonene 
2,4-Dimethylfuran 2-n-Pentylfuran 
2 2-Pentanone 4-Ethoxy-2-pentanone 
2-Methyl-3-pentanone Cyclohexanone 
3-Methyl-2-pentanone 3-Octanone 
4-Methyl-2-pentanone 5 Allyl isothiocyanate 
1- Propanol 2-Octanone 
2-Methyl-5-ethylfuran (tent) Acetic acid 
Dimethyl disulfide 6 Pyrrole 
3-Hexanone Benzaldehyde 
3 2,3,5-Trimethylfuran 2,3-Butanediol 
2-Hexanone γ - Valerolactone 
2-Methyl-1-propanol α -Terpineol 
5-Methyl-3-hexanone (tent) γ - Hexalactone 
3- Penten-2-one Carvone 
4-Methylpent-3-en-2-one (tent-) δ - HexaIactone 
4 4-Heptanone 9 Dimethyl sulfone 
Cyclopentanone 4-Methyl-5-hydroxyhexanoic acid 
2-Methyltetra hyd rofu ran-3-one (tent) Lactone(tent) 
3-Heptanone ρ - Cresol B 
Table 1.  Volatile Constituents in Human Urine (Adapted from [77]). 
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Volatile Compounds in Urine of ICR/ALB Male Mice 
Class of compounds  Structure  
Dihydrofurans  mol wt 126  
  mol wt 126  
  mol wt 126  
Ketones 2-Heptanone  
  5-Heptene-2-one  
  4-Heptene-2-one  
  3-Heptene-2-one  
  6-Methyl-6-hepten-3-one  
  6-Methyl-5-hepten-3-one  
  Acetophenone  
Acetates  n-Pentyl acetate  
  2-Penten-l-yl acetate  
Dehydro-exo-brevicomin    
2-(sec-butyl)-4 ,5-dihydrothiazole    
Sesquiterpenes  β-Famesene  
  α-Farnesene  
Table 2.  Volatile Compounds in Dominant and Subordinate Male Mouse Urine (Adapted 
From  [76]). 
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Approaches to Volatile Sampling 
 Volatile sampling may be performed using a variety of approaches, each of which 
come with their own advantages and disadvantages in such areas as analyte sensitivity 
and selectivity of volatiles sampled, form factor (sampler/sensor footprint), and 
time/cost of analysis. Additional consideration must be given to any volatile study to 
determine the best approach with the principal concerns being: experimental 
scale/number of samples, are the compound(s)/subspecies of interest known, and is 
absolute quantitation required. To understand the implications of the above in the real-
world applications described and proposed below, a brief overview of volatile sampling 
techniques is required. 
 The majority of air sampling for volatiles performed in both the laboratory 
setting and environmental field monitoring is a variant of a "grab" sample. Grab samples 
consist of a single, finite time slice of the atmosphere captured during the sampling time 
period and provide the concentration of a volatile mixture for only the actual time slice 
comprising the collection (i.e. a still picture versus video). The time slice may be 
extended through the manipulation of flow rates across a sensor or modifying diffusion 
to a media, but inevitably are limited in that the reported concentrations are a time 
weighted average of the time of collection, which does not allow for discrimination of 
short duration increases or decreases in analyte concentration. Time-series collections 
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through the sequential acquisition of grab samples is possible as is the continuous, 
"real-time" monitoring of a volatile sample space through solid state sensors. Both of 
these approaches have limitations, with space, power, and increased analysis 
requirements being principal concerns for the time-series grab samples and limited 
analytical resolution and discrimination being foremost for real-time sensors (i.e. only 
good for a given analyte or analyte sub-set). Below is a brief description of some of the 
most commonly used volatile sampling techniques along with their associated 
advantages and disadvantages. 
 The gold standard for volatile "grab" sampling is the summa canister, a stainless 
steel electro-polished (or "summa" polished) passivated vessel, generally in a spherical 
or cylindrical format. Summa canister are available in a variety of sizes (100ml to 10L), 
contain a valve and gas tight fitting for sample inlet, and are "re-conditioned" (cleaned) 
and evacuated prior to collection. Additional accessories which can be used in 
conjunction with summa canisters to allow for time-weighted, longer duration 
collections are flow controllers and critical apertures/orifice assemblies, and analog 
gauges.  For typical air grab sampling using summa canisters, the summa canister valve 
is opened and the canister is left in a designated area for a period of time to allow the 
surrounding air to fill the canister and achieve a representative sample. The valve is then 
closed and the canister is sent to a laboratory for analysis. Summa canisters are typically 
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analyzed via GC/MS according to the EPA's guidelines for air, such as methods TO-14 
and TO-15 [78] and are the only way to trap the lightest of the freons and inorganic 
(permanent) gases such as O2, O3, CO2, SO2, NO2, etc.  However, compared to other grab 
sampling techniques, summa canisters are more expensive, have a large physical and 
logistical footprint, require manual sampling and additional high-cost equipment to be 
compatible with most GC systems, and are limited in their volatile capture range to 
compounds with 10 carbons or less [79]. Another common approach to volatile grab 
sampling are gas sampling bags such as the Tedlar® bag.  Tedlar® bags require either 
manual (i.e. hand pump) or active pumping of air using a portable sampling pump into 
these relatively less expensive bags which can then be returned to the lab for analysis. 
Analysis is generally performed either by injecting the air in the bag directly into a 
sorptive device to concentrate low levels of VOCs, followed by desorption into the 
GC/MS, or by aspiration and injection via a gas tight syringe into a sealed headspace vial 
(less sensitive) and analysis by GC/MS. Principal limitations for gas bag sampling are 
limited sample stability and associated difficulties in sample transport/shipment, large 
sampling footprint, and volatile condensation on the bag surface requiring heating 
immediately prior to analysis. 
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 Another approach to air sampling is the passive collection of volatiles onto a 
sorbent media. Passive sampling is widely used in both the industrial and environmental 
setting and is particularly useful in many applications that are space limited and/or 
require long term monitoring, such as in workplace personnel assessments. The devices 
used for passive sampling are usually based on diffusion through a well-defined 
diffusion barrier or permeation through a membrane. The analyte concentrations 
obtained using the passive samplers are a time weighted average, and are limited to the 
capture range of the media utilized. One of the most commonly utilized passive 
samplers is the badge type device, which is commercially available from numerous 
manufacturers such as 3M and SKC [80]. These devices do not require any active 
sampling pumps but generally need exposure to the sample air for considerably longer 
times (4 hrs or more) for low level detection. Quantitation requires calculation based 
upon published uptake rates for each individual volatile on a given passive sampler and 
both open source literature [81] and recent consultation with NIOSH have shown that 
this sampling approach has been proven less reliable and reproducible for quantitative 
studies than actively, pumped samples.  
 One of the most commonly used passive media formats is solid phase 
microextraction, or SPME.  SPME, which has other commercial analogues such as SPE-td 
(or SBSE aka “Twister”) is a licensed, passive sampler available from Supelco (Bellefonte, 
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PA).  Most GC sample preparation procedures using based on solvent extractions have 
been time-consuming, labor intensive, multi-stage operations. All of these steps, 
especially concentration via solvent evaporation, introduce errors and losses, especially 
when analyzing volatile compounds.  Additionally, waste solvent has to be disposed of, 
adding to the expense of the procedure.  Many of these limitations have been reduced 
through the use of solid phase extraction (SPE), but this technique is still time 
consuming and generally requires a concentration step.  Solid phase microextraction 
(SPME), was invented by Pawlisyzn at the University of Waterloo (Ontario, Canada) in 
1989 [82, 83], and addresses these limitations by integrating sampling, extraction, 
concentration, and sample introduction into a single step.  SPME utilizes a short, thin, 
solid rod of fused silica (typically 2 cm long and 0.11 mm OD) coated with an adsorbent 
polymer. The fiber is the same type of chemically inert fused silica used to make 
capillary GC columns and is stable at high temperatures [84].  The SPME extraction 
consists of two processes: analytes partition between the sample and the fiber coating; 
and the concentrated analytes desorb from the coated fiber to an analytical instrument.  
SPME extraction is a complex multiphase equilibrium process. An extraction can be 
considered complete when the concentration of analytes has reached distribution 
equilibrium between the sample and coating (amount extracted is independent of 
further increases in time). The higher the distribution constant of a compound, the 
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higher the affinity of that compound for the SPME fiber coating [85].  In general, the 
distribution constant for an analyte increases with increasing molecular weight and 
boiling point.  The equilibrium conditions can be described as:    
            
         
 where n is 
the amount extracted by the coating, Kfs is a fiber coating/sample matrix distribution 
constant, Vf is the fiber coating volume, Vs is the sample volume, and C0 is the initial 
concentration of a given analyte in the sample [85]. 
 There also exists a linear relationship between the amount of the analyte on the 
fiber extracted and its initial concentration Cs,0 in the sample if the extraction time is 
long enough for equilibration, the dynamic range of the method is not exceeded and all 
other experimental conditions (sample composition, temperature, volumes of sample, 
and headspace) are held constant [85]: 
 
n = const x Cs,0 where    
             
                 
 
 
 The above equation still holds true if the extraction is interrupted after a 
constant time before the equilibrium is attained [86].  In SPME, detection limits depend 
on the distribution constants and polarity of the analytes but are often in the ppt. For 
example, with a 100 um polydimethylsiloxane (PDMS) fiber, nonpolar compounds with 
high distribution constants have lower minimum detection limits than more polar 
24 
 
analytes with lower distribution constants. Branched aromatic compounds and 
chlorinated alkenes exhibit the lowest detection limits [87]. 
 As the extremely volatile compounds can begin to leave the fiber before the 
sample is injected, it is best to minimize the time between extraction and desorption 
and to maintain consistent timing for each step.  Some of the advantages of SPME over 
other approaches such as summa canisters are: it is a passive sampling technique and 
takes only a few minutes for equilibration; the “clean” sampling matrix provides an 
accurate volatile baseline; lower sample cost and smaller footprint versus a summa 
canister; and will detect material with higher boiling points than benzene, like engine or 
mineral oil hydrocarbons [88]. Significant downsides to SPME are that sufficient analyte 
may not be absorbed by the SPME fiber for quantitation if the total concentration is 
very low, SPME volatile mixture capture is limited low sample capacity and competitive 
displacement, there is no easy way to automate analysis for high volume testing, and 
sample breakthrough/loss becomes a large concern for extended exposures or in a high 
flow environment and limits stability on fiber. Additionally, only one analysis per 
sampling event is possible as the fiber is completely reconditioned after each injection. 
With other techniques listed above (i.e. summa canister and gas bag), the analyst may 
perform multiple trials / sample injections into GC/MS with just one sampling event. For 
the field sampling pipeline proposed in this study, the fibers would require transport at -
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4°C. Even under these conditions, prior experience in our laboratory [89] has 
demonstrated that it is likely not possible to store the SPME fiber for 3 days or more 
post sampling and recover highly volatile organic compounds such as chloromethane, 
but the technique does remain viable for less volatile compounds (i.e. naphthalene and 
dichlorobenzenes).  It must also be noted that after discussions with scientists directly 
involved with development of SPME in the laboratory of Dr. Janusz Pawliszyn [90], the 
use of sorption tubes, described below, is certain to be more quantitatively accurate 
than SPME due to the competitive binding nature and limited surface area of the SPME 
fibers.  
 Arguably the most versatile and accurate approach to unknown atmospheric 
mixtures characterization are the active sampling techniques. Active sampling requires 
forced airflow through the collection media using either a pump or in-line series/parallel 
flow.  The most commonly utlized active media format in environmental monitoring for 
this purpose is the thermal desorption (TD) tube.   
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Although TD tubes may be used in the passive role (see below), they are primarily used 
in conjunction with an actively pumped system. These tubes are analogous to thermal 
desorption traps used in GC/MS to concentrate VOCs in a headspace analysis or trap 
columns used in liquid chromatography. TD tubes allow for collection of volatiles by 
channeled air flow though the capture packing material using miniaturized sampling 
pumps at the testing site. The TD tubes are then either thermally desorbed (i.e. via 
commercial autosamplers) or solvent desorbed for analysis. When utilized for passive 
sampling, as gases will diffuse in (and out of) both ends of the tube, all the passive 
sampling work is generally done with a single sorbent bed in the tube.  Doing this limits 
the boiling point range covered, making this method somewhat constrained in that the 
analyte being measured should be previously determined.  As diffusion drives this flow, 
breakthrough is not a concern, however, low boiling materials may diffuse back off of 
the tube (i.e., diffusion is a two way process). This is particularly important if the nature 
of the gas being monitored changes and has a lower concentration of the target analyte 
than the original gas.  Depending on the duration for which the sample air is pumped, 
sorption tubes can either be considered as grab sampling or time weighted average 
sampling (i.e. ~5mins can be considered as grab sampling vs. 4hrs at low flow rates 
considered as time weighted average sampling). One feature which contributes greatly 
to the use of TD tubes for unknown or mixtures detection is the availability of multi- 
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Figure 2.  Multiple sorbent beds present in tri-bed thermal desorption tube utilized 
for EPA Method TO-17. 
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phase packing materials capable of capturing a wide range of volatiles, such as in the 
tribed tubes recommended for use in EPA method TO-17 ("Air Toxics"), example shown 
in Figure 2.  It is due to this versatility and spectrum of commercially available sorbents 
that TD tube use is widely reported for breath sampling for biomarker discovery [91, 
92]. 
 
Data Analysis 
 To fully appreciate the parallels between GC-LC/MS and the other -omics data 
sets described above and the associated requirements for post-acquisition analysis, a 
basic understanding of the raw chromatographic and spectral data obtained is needed. 
Using the example of an acquisition performed by GC/MS, a typical sample consisting of 
an unknown mixture of interest is introduced into the heated sample injection port (i.e. 
via SPME) and flushed by an inert carrier gas, generally helium, onto the head of the 
capillary column. The columns used by our laboratory are fused silica open tubular 
(FSOT) format columns and consist of a fused-silica capillary tube whose walls are 
coated with liquid stationary phase. Without delving too deeply into issues surrounding 
stationary phase selection, thickness, and their relevance to the principals of optimized 
theoretical plate separation, column types are determined based on the physical 
property selected as the best candidate for separation of the individual components of 
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the mixture of interest (i.e. polarity or hydrophobicity) as well as the sample capacity 
required.  As the complex mixture is pushed through the column and interacts with the 
bound stationary phase, individual components are pulled apart based on the physical 
property of the column type, and under optimal conditions, elute as discrete, Gaussian 
peaks into the detector (mass spectrometer) over a chromatographic time scale, 
generally measure in minutes, giving the first dimension of each sample run.  For the 
two, additional sample dimensions, we must look at the detector utilized, the mass 
spectrometer.  According to Silverstein [93], the concept of mass spectrometry is 
relatively simple: a compound is ionized (i.e. via electron impact, or EI,  in the case of 
GC/MS), the ions are separated on the basis of their mass/charge (m/z) ratio, our 
second dimension, and the number of ions representing each m/z unit is recorded as a 
spectrum.  The intensity of each individual ion can be correlated to relative intensity, 
and it is this intensity which gives us our third dimension. When all three dimensions are 
viewed either as a heat map or surface (Figure 3), the data feature similarities between 
GC-LC/MS, genomic (i.e. gene-chip), and proteomic (i.e. 2D-SDS PAGE gels) become 
readily apparent. Analysis issues such as image alignment, feature registration, data 
visualization, and differential profiling are all required, and lessons learned in the more 
mature fields, such as genomics, are directly applicable to the analysis of metabolomic 
data.   
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Figure 3.  Chromatographic and mass spectral data showing the three axes of time, m/z, 
and intensity and example analysis techniques utilized in differential molecular profiling 
studies. 
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CHAPTER 2.  RESEARCH QUESTION AND DESIGN  
 
Problem Statement 
 To illustrate the data gap in both sampling and analyzing real-world needs in 
molecular profiling, following is a widely reported issue identified with USAF aircraft 
where numerous knowledge and capability gaps exist in the molecular characterization 
of the operational environments faced by today’s Airmen.  In 2011, the entire F-22 fleet 
was grounded for nearly 5 months due to a series of incidents where pilots had 
experienced unexplained symptoms such as shortness of breath, disorientation, 
confusion, and headache, among other symptoms. This has led to a myriad of formal 
investigations that have identified aircraft systems limitations as well as a need to 
improve our analytical toolset and understanding of the environments encountered in 
the F-22 and other high performance aircraft, and their effects on the humans operating 
them.  In the midst of these high profile investigations, ground maintenance personnel 
have also had a series of incidents where they have experienced symptoms such as 
dizziness, headache, and nausea while performing engine ground runs.  These incidents 
have had a similar response effort undertaken for them where possible, to include 
environmental samples out of the cockpit air supply, but have found no specific cause 
from that methodology.  Unfortunately, the response methodology was tailored to in-
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flight emergencies, and given that testing capabilities are more numerous on the 
ground, this issue has not been explored as much as possible.  A comprehensive 
exploration of the associated chemical environments will require both the application of 
existing sampling tools (described above), development of novel analysis techniques, 
and improvements in large scale environmental differential profiling.  Additionally, 
extensive evidence exists on the uniqueness and dynamics of molecular, and particularly 
mass spectral, signatures of liquids and gases for use in identification of materials, 
phenotypic states, and environmental conditions.  These operational concerns must be 
addressed through the development and application of both novel sampling tools and 
novel applications of available media for the detection and identification of potential 
contaminants and other performance degrading conditions experienced both on the 
ground and in-flight.  The scope and scale of these studies will also be limited due to the 
availability of informatics tools capable of the 1000's of generated sample sets.  Current 
LC/MS and GC/MS systems typically consist of a system of specialized instrumentation 
with customized support software.  This software is generally proprietary, being 
supplied by the instrument manufacturer, and is primarily designed to facilitate user 
interaction with the analytical hardware.  Most manufacturers also market add-on 
commercial software packages for the analysis of the results of LC/MS and GC/MS 
experiments, which provide a limited tool set for a specific type of data analysis (i.e. 
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proteomic or metabolomic), generally with a focus on pharmaceutical development 
needs, and which cannot be readily modified or added to by the end-user as various 
study needs arise.  For larger molecular profiling and biomarker discovery studies, such 
as the LC-GC/MS efforts undertaken by our laboratory, none of the software solutions 
reviewed [94-99] offer the ability to compare multiple time point and exposure groups, 
or handle data sets in significant sample numbers.  Due to the need to implement a 
wide spectrum of differential algorithms required for individual studies as well as the 
undocumented "black box" nature prevalent in much of the vendor and recently 
available open source tools/algorithms (possibly inducing unknown bias in obtained 
results), creation of a novel, modular informatics tool set allowing processing of the raw, 
chromatographic and spectral data was required. 
 
Hypothesis 
 The core hypothesis tested during the course of this work is that an informatics 
tool can be designed that provides spectral registration, spectral and chromatographic 
alignment, visualization, and comparative analysis for data generated from multiple 
analytical platforms, i.e. LC-MS and GC-MS.  Comprehensive and reproducible sample 
collection techniques were developed concomitantly with the informatics tool and used 
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in multiple, independent studies for the validation and further development of 
generated software tools and approaches. 
 
Technical Objectives 
 As stated earlier, the key requirements to any empirically based study are to (1) 
accurately measure and then compare the collected results in determining the result of 
the hypothesis being tested, and (2) collect a sample representative of the entities being 
studied.  For measurement in metabolomic studies focused on volatile and small 
molecule profiling (i.e. 41-1000 m/z), the standard method of approach is GC or LC/MS 
with associated support software. In addition to the proprietary instrument driver 
software supplied by the instrument manufacturer , most GC-LC/MS manufacturers also 
market add-on commercial software packages for the analysis of the results of MS 
experiments, which are meant to fill the gap in data processing and provide a very 
specific type of analysis (i.e. proteomic or metabolomic for drug discovery/metabolism) 
and cannot be modified or added to by the end-user. For larger metabolomic profiling 
studies, such as the efforts completed in support of this work, none of the software 
solutions available at the time this effort was initiated offered the ability to compare 
multiple sample groups and handle data sets in significant sample numbers (i.e. >500 
samples).  This bottleneck in data handling was the impetus for the development of the 
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informatics tools generated.  The second requirement for the creation of this analytical 
pipeline was the design and execution of novel capture techniques and/or the down-
selection of the best commercially available (if experimental criteria are met), with a 
focus on collecting comprehensive samples to meet the need for the complete 
characterization of the samples/environments of interest.  In summary, the overall 
objectives of this work were to develop and implement an implement an analytical 
pipeline to:  (1) identify differential molecular signatures and biomarkers of materials, 
phenotypic states, environmental conditions, and individual/group differences; (2) 
enhance existing mass spectral differential profiling capability, allowing for optimally 
targeted unknown compound identification for potential subsequent incorporation into 
sensor platforms; and (3) conduct associated field sampling in support of operational 
needs.  We achieved the objectives of this work through pursuit of the following three 
specific aims. 
 
Specific Aim 1   
 To test the hypothesis that the design and utilization of a novel, prototype 
software tool for feature registration, and spectral and chromatographic alignment will 
facilitate analysis of large scale studies for LC/MS based biomarker discovery and small 
molecule profiling, and allow the ability to visualize the data for a global view of an 
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entire experiment, while still maintaining the ability to focus on individual metabolites 
and spectra for subsequent identification.   In support of this aim, a prototype software 
tool (described below) was designed in Matlab 2010a (The MathWorks Inc., Natick, MA) 
for LC/MS based spectral registration and alignment.  A preliminary data set from a 
biomarker discovery experiment to identify low lever markers of organ specific damage 
was utilized for this proof of concept study.  LC/MS based metabolomic analysis was 
performed using the Waters Acquity® ultra-performance liquid chromatograph coupled 
to a Waters QToF® hybrid tandem quadrupole/time of flight mass spectrometer 
equipped with a Lockspray electrospray source operating in positive ion mode.  The 
resulting spectra were analyzed using this prototype software tool. 
 
Specific Aim 2 
 To test the hypothesis that the combination of a suite of basic comparative 
algorithms, logical operators, and statistical filters in conjunction with an integrated set 
of machine learning tools for feature down-selection will allow for the efficient analysis 
of GC/MS based spectral data to support volatile biomarker and gas phased-differential 
molecular profiling studies.  In support of this aim, modifications and enhancements 
were completed on the prototype software tool created in Aim 1 to allow for the 
visualization and analysis of GC/MS acquired experimental data in support of multiple 
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VOC  based biomarker and molecular profiling research.  Initial GC/MS based 
metabolomic analysis were performed using a Thermo Scientific (Waltham, MA) Trace 
GC Ultra®  gas chromatograph interfaced to a Thermo Triplus®  autosampler configured 
for automated SPME headspace sampling and in-line with a Thermo DSQII®  single 
quadrupole mass spectrometer.  Further validation of this tool and approach to 
analytical studies were conducted on a variety of volatile profiling studies, to include 
phenotypic characterizations of a urine murine model, as well as other data sets, 
including environmental studies, to demonstrate versatility of the approach. 
 
Specific Aim 3 
 To test the hypothesis that the creation and execution of a logically designed 
work flow for large-scale analytical studies in differential molecular profiling, essential in 
both environmental and biological screening studies, requires not only an efficient data 
analysis pipeline, but also the design and execution of novel capture techniques focused 
on collecting comprehensive samples, allowing for the complete characterization 
necessary.  Studies which require complete characterization of an unknown, whether it 
is biologically derived, such as human breath, or environmental, as in the case of fighter 
cockpit air, necessitate varied approaches to collection for accurate and broad-spectrum 
capture of all potential molecular species present. In support of this aim, a thermal 
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desorption tube based approach to sample collection for in-flight, pilot air supply was 
performed with follow-on analysis being completed utilizing a modified version of EPA 
Method TO-17 for monitoring VOCs via automated, cryogen-free TD using a Markes Intl 
TD100® in line with a Thermo Scientific Trace GC Ultra® and ISQ® single quadrupole 
mass spectrometer.  The thermal desorption GC/MS system was calibrated with a 
standard of target 65 VOC analytes, including selected aliphatic and aromatic 
hydrocarbons, ketones, alcohols, esters and halogenated organics such as Freons and 
chlorinated solvents. In addition to the target compound analysis, we identified 
detected compounds and estimated quantities for all major non-target chromatographic 
peaks using mass spectral library search procedures. 
 
Experimental Design 
 As the goal of this work was to design and implement an end-to-end sample 
collection to results pipeline, to include a prototype software tool, incorporation of 
multiple, independent studies were required for development and validation of 
generated tools and approaches. The principal bottleneck to any study of this type is the 
data processing and analysis, thus the first aim was to address this through the 
development of a prototype spectral analysis platform. To both answer an active  
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  Focus Data Type(s) Supporting Experiment(s) 
Aim 1 Foundational software framework to include  
     spectral registration and alignment 
LC/MS Small molecule biomarker discovery in F344 model for low level    
     organ selective toxin exposure 
Aim 2 GC/MS data functionality - chromatographic time  
     binning and fold change 
GC/MS Characterization of the binding between volatile ligands and  
     murine major urinary proteins                                                                     
Volatile characterization of murine urine as it ages                  
Volatile characterization of human urine as it ages 
  Data filtering and normalization techniques GC/MS Human volatile markers of age and ethnicity in axillary odor profiles 
  Novel hybrid evolutionary classifier for biomarker  
     discovery 
GC/MS Murine model of urine based volatile makers of infection to select  
     agents 
Aim 3 Novel sampling technique for comprehensive  
     assessment of volatile contaminants 
GC/MS In-flight air quality assessment of the combat air fleet using a novel  
     sampling approach 
Table 3.  Foci, data types, and major experiments completed in support of aims.  
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research need and aid in the development and illustration of the novel visualization and 
rapid multi-sample analysis capability of the tool for discovery of metabolomic 
biomarkers, use of data from a dose-response study examining environmental toxicant 
exposures was performed. 
 The next goal of this study was to expand both the capabilities of the informatics 
tools and develop a suite of optimized techniques for analysis of volatile based 
metabolites. Using the same approach as for the LC/MS data analysis, a variety of 
studies focused on volatile biomarker discovery were processed with the enhanced 
informatics tool to: aid in algorithm and interface development; provide validation of 
generated results; and to prove its utility.  To demonstrate the various processing, 
algorithmic, and data filtering requirements addressed, a wide range of study types 
were processed.  Experiments examined in support of this aim included: a murine model 
of infection to select agents, characterization of human and murine urine as it ages, 
human markers of age and ethnicity in axillary odors, and characterization of the 
binding between volatile ligands and murine major urinary proteins (MUPs). 
 The final goal of this work was to utilize the analysis tools and workflow 
developed in the first two aims in combination with both optimized and novel sampling 
techniques to create an end-to-end discovery pipeline for large-scale small molecule 
and volatile organic compound biomarker and differential profiling studies.  An 
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environmental health and safety focused study of the cockpit atmosphere was assessed 
as final proof of concept and demonstrate the universal utility of the approach. 
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CHAPTER 3.  FOUNDATIONAL SOFTWARE FRAMEWORK  
 
Overview 
 The goal of this work was to design and implement a prototype software tool for 
the visualization and analysis of small molecule metabolite GC-MS and LC-MS data for 
biomarker discovery. The key features of the Metabolite Differentiation and Discovery 
Lab (MeDDL) software platform [100] include support for the manipulation of large data 
sets, tools to provide a multifaceted view of the individual experimental results, and a 
software architecture amenable to modification and addition of new algorithms and 
software components. The MeDDL tool, through its emphasis on visualization, provides 
unique opportunities by combining the following: easy use of both GC-MS and LC-MS 
data; use of both manufacturer specific data files as well as netCDF (network Common 
Data Form); preprocessing (peak registration and alignment in both time and mass); 
powerful visualization tools; and built in data analysis functionality.  
 To illustrate the novel visualization and rapid multi-sample analysis capability of 
MeDDL for discovery of metabolomic biomarkers, data from a portion of a study 
examining environmental toxicant exposure has been selected.  Environmental 
exposures to toxins as well as therapeutic interventions often cause 
nephrotoxicity[101].  An expanded list of metabolites indicating kidney damage would 
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be immensely helpful in the monitoring of renal conditions after exposure to external 
toxicants, not only in pharmaceutical drug safety evaluations and clinical studies, but 
also in the occupational and military operational setting.   
 As reported previously by our group [102], D-serine is ubiquitous in human 
plasma and composes up to 3% of total plasma serine level in humans, with plasma D-
serine elevations observed in chronic renal failure, suggesting elimination by the kidney 
is responsible for control of D-serine concentrations. D-serine is reabsorbed in the pars 
recta region of the rat proximal tubule and subsequently metabolized by D-aminoacid 
oxidase (D-AAO), to produce α–keto acid, ammonia, and hydrogen peroxide [103, 104]. 
Other research has indicated that metabolism of D-serine by D-AAO is causative for 
initiation of toxicity in the kidney, with elevated levels generating selective necrosis to 
the pars recta region of the renal proximal tubules in the rat[105].  The choice to use the 
D-Serine model was made in order to reveal both early and sensitive biomarkers for 
epithelial cell injury in the kidney.   
 
Urine Samples and Materials  
 Animal use in this study was conducted in accordance with the principles stated 
in the Guide for the Care and Use of Laboratory Animals, National Research Council, 
1996, and the Animal Welfare Act of 1966, as amended.  Male Fischer 344 rats weighing 
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222–258 g were obtained from Charles River Laboratories.  Groups of five animals 
received a single intraperitoneal (IP) dose of d-serine at a dose of 5, 20, or 500 mg/kg (or 
vehicle only - 0.9% saline solution).  Food (Purina Certified Rat Chow # 5002) and water 
was available for all animals ad libitum. The housing environment was maintained on a 
12 hour light-darkness cycle at 25°C, and all animals were examined by Vivarium 
personnel twice daily. Urine samples were collected cold using plastic 50 mL conical 
tubes containing 1.0 mL of 1% sodium azide maintained at 6-10°C using I-Cups 
(Bioanalytical Systems, Inc.; stored at -80°C prior to use) 24 h prior to dosing and daily 
thereafter, generating five twenty-four hour intervals (0, 24, 48, 72, and 96 hours post-
dosing).  The urine was then frozen at -20°C and thawed on ice prior to analysis. For the 
D-serine exposure set described, 104 individual samples were processed by aliquoting 
1.0 ml of urine into a 2 ml centrifuge tube and centrifuged at 13,000 RPM for 5 minutes 
at 5°C to remove debris.  The supernatant was removed using a 1 mL tuberculin syringe 
and filtered through a 0.2 μm PTFE syringe filter disc prior to aliquot transfer to two 
Waters Corp. Total Recovery Vials and subsequent duplicate testing. 
 
Instrumentation and Methods 
 The LC/MS system utilized for sample analysis was a Waters Q-ToF Micro in line 
with a Waters Acquity UPLC.  The source temperature was set to 130°C, a desolvation 
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gas temperature of 320°C and a desolvation gas flow of 600 l/h were employed.  The 
capillary voltage was set at 3.2 kV for both positive and negative ion mode analysis.  A 
scan time of 0.4 s with an inter-scan delay of 0.1 s was used throughout, and data was 
collected in centroid mode.  A 1μl aliquot of filtered urine was injected onto a 
2.1x100mm, 1.7μm Acquity UPLC BEH C18 column (Waters Corporation) held at 40°C. 
Retained small molecules were eluted via a linear gradient of 98% A for 2 min, 2–50% B 
from 2–11 min, 50–98% B over 12-12.49 min, returning to 98% A at 12.5 min and 
remaining there until completion of the run at 15 minutes at an eluent flow rate of 0.25 
ml/min; where A = 0.1% formic acid and B = 0.1% formic acid in acetonitrile. T he mass 
spectrometric data was collected in full scan mode from m/z 80 to 1000 from 0.8 to 15 
minutes.  Urine samples were run in duplicate and analyzed using MeDDL using spectra 
from 0.8-12 minutes.  For ms/ms data, random urine samples were run using data 
dependent acquisition with multiple voltages applied. Standards were purchased from 
Sigma-Aldrich (St. Louis, MO) and run at 1 mg/ml (1ug injection) under the same LC-MS 
conditions as the samples to validate retention times and ms/ms spectra. Sample 
analysis for determination of differential metabolites was performed using the MeDDL 
tool which is described below.    
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Algorithms And Implementations 
 The overall goal of the MeDDL system is to facilitate the analysis of LC-MS 
experimental results.  With this goal in mind, the system is structured to provide a 
global view of experimental results so a user can quickly identify samples exhibiting 
interesting or unusual patterns of behavior while still having the option to probe these 
samples at ever finer levels of detail.  MeDDL accomplishes this by allowing the user to 
search for relationships between subsets of subjects at selected times or treatment 
levels. The user may ask for subsets which exhibit specific levels of change in the 
behavior of the response.  The user may restrict the fold-change to positive, negative or 
combined levels of changes.  For example, the user can seek all peaks that exhibited a 5 
fold positive change between the control subjects and treated subjects at 24 or 48 
hours.  In addition, MeDDL also allows the user to perform detailed statistical analysis 
including ANOVA (1-way, 2-way and N-way) among the selected subject groups.  The 
user can optionally perform multiple pairwise comparison tests among the means of 
groups to determine whether or not all differences- among group means satisfy a user 
defined level of significance.  A Bonferroni correction is applied to compensate for the 
tendency to incorrectly find a single pairwise significant difference among multiple 
comparisons. 
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 The MeDDL system is composed of two major subsystems: peak analysis and 
visualization.  Peak analysis encompasses several subsidiary tasks including peak 
extraction, peak registration and extraction of registered peaks sets.  The visualization 
system takes the information provided by the peak analysis subsystem and combines it 
with information describing the overall experiment to allow the user to explore the 
results from the perspective of the experimental parameters.  
 
Peak Analysis Subsystem  
 In this section, we present a brief overview of the algorithms that comprise the 
peak analysis subsystem.  As shown in Figure 4 these algorithms include peak extraction, 
peak registration and peak matching.  Each algorithm is described below. 
 The peak extraction algorithm is composed of two phases.  The first phase is 
designed to form temporal clusters required for chromatographic time alignment and 
the second phase partitions clusters into individual peaks.  A full experiment consists of 
hundreds of files from different LC-MS sample runs, each of which is identified by 
subject, treatment, time, and optionally replication indices.  A single LC-MS sample is 
composed of a set of n measurement points P = [ pi | i = 1, 2, 3, … n ] of the form: 
pi = (Mi,Li, Ii) with components of mass (Mi), scan number (Li) and intensity value (Ii).  
Each scan (Li) also has a corresponding retention time (Ti).  Extracted peaks are temporal  
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Figure 4.  Schematic overview of the peak analysis subsystem. (A) Sample peak cluster 
extraction. (B) Sample peak cluster partition. (C) Preliminary peak matching for 
registration. (D) Matched Peaks. pi,j = <Mi,j, Ti,j, Ii,j> – apex point of extract peak with 
mass (Mi,j), register time (Ti,j) and intensity (Ii,j). The behavior of each row is summarized 
by the average mass (Mavg,i), average registered time (Tavg,i), average intensity (Imax,i) and 
a count of the number of peaks detected (Ni) (from Grigsby et.al. 2010). 
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sequences of similar mass coordinates across multiple scans.  A simple example of the 
algorithm for forming peak clusters is shown in Figure 4A.  
 The peak extraction process is initialized by selecting a reference point (Ma, La, Ia) 
with a large intensity which will become the apex of the resultant peak bounded by a 
narrow mass band.  The width of the mass band is set by a mass uncertainty parameter 
(Δm) specified by the user.  Within this mass-band, points are assembled into cluster 
sequences in both temporal directions from the initial reference point, accepting only 
one point per scan.  A resultant cluster may grow to lengths spanning many peaks.  
 The next step, partitioning the cluster into individual peaks, is a difficult design 
problem, because it must instantiate a peak definition that separates the significant 
peaks from the noisy and uninteresting ones.  Often, partitioning a cluster visually can 
be difficult, so some ambiguous results are unavoidable.  In other words, if it is difficult 
to resolve peaks visually, it is difficult to automate.  In Figure 4B there are many small, 
jagged, noisy peaks and three or four prominent peaks.  The decision to extract 3 or 4 
peaks is determined by adjusting a user-accessible control parameter.  In this example, a 
closing operator from mathematical morphology [106] has been employed to filter out 
unwanted peaks, including the fourth obvious candidate.  The horizontal fill-in lines are 
determined by the size of the structuring element used by the morphological operators 
to probe the cluster’s structure. 
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Peak Registration 
 Peak registration uses only mass and retention time coordinates (Ma,Ta) of the 
peak apices to achieve the significant data reduction required to work efficiently across 
many LC-MS samples.  Peak registration primarily involves temporal alignment of peaks, 
although for some instruments the alignment of mass measurements is also required. 
Initially, one of the images is selected as the reference image and all others are 
transformed to match it.  As illustrated in Figure 4C, this transformation is accomplished 
by bracketing each peak with a maximum shift window (Δm, Δt) and identifying matching 
pairs of peaks. Ideally, these are one-to-one unique matches, meaning each peak has 
only one unique candidate match. A larger set of candidate matched peaks can be 
defined by relaxing the criteria so that only the peak in either the reference image or 
alignment images has a unique matching peak. The set of matched peaks is then used to 
compute a polynomial transformation that maps retention times of images relative to 
the reference image. The order of the polynomial is determined by the user (Eq. 1).  
                              
                   Eq. 1 
Should the need arise to make adjustments to mass coordinates (Eq. 2); the set would 
be used to compute a bivariate alignment polynomial.  
                                                                         Eq. 2a 
                                                                        Eq. 2b 
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Peak Matching 
 The set of matching pairs of peaks is used to initialize a matrix of matched peaks 
(Figure 4D).  Each column represents one image and each row contains a set of 
registered peaks.  The peak coordinates (Ma, Ta) are averaged over non-empty images in 
each row (Mavg,Tavg), producing a synthetic reference image so that the original 
reference image is no longer required.  A number of cycles of the matching algorithm 
are then used to fill in existing rows and to extend the number of rows by seeding the 
reference image with peaks from the pool of unused peaks.  The coordinates of the seed 
peaks are used as initial values for (Mavg,Tavg).  Each iteration of the matching algorithm 
produces new alignment polynomials by pairing image peak coordinates with the 
evolving row averages.  A peak matches the row average if its coordinates fall within a 
(Δm, Δt) box centered on the row average, where Δt is much smaller than the Δm used for 
pre-alignment matching pairs.  The final matching step, which attempts to fill in any 
empty slots in the matching matrix, is accomplished by selecting the raw data point with 
the maximum intensity in the (Δm, Δt) acceptance box as a peak substitute.   
 
Visualization System  
 The visualization system is based on the MVC (model-view-controller) software 
architecture pattern [107].  The model is composed of a series of relational data tables 
52 
 
that include the registered match peak table (Figure 4D), the experimental descriptor 
table, cluster-peak data tables and raw sample data tables.  The user interacts with the 
model via a graphical interface that supports mouse and keyboard input.  The 
communication between the controller and the model is implemented using callback 
mechanisms defined in the Matlab programming language.  When the user triggers a 
callback event, the controller notifies the model of the user’s action and then possibly 
alters the state of the model.  The view may automatically be invoked by the controller 
to update some subset of displays as a result of a change in the state of the model or 
the view may query the model to generate a display based on a user request.  
 The user interaction with the model is organized into a collection of filters that 
allow the user structured access to the various components of the data model (Figure 
5).  These filters are divided into logical categories: data, statistical, chemical, and 
experimental.  The data filters allow access to subsets of data that are restricted by 
mass, retention time or intensity.  The statistical filters allow the user to locate 
statistically significant patterns of behavior across the entire set of registered peaks.  
Chemical filters allow the user to remove certain peaks from the analysis based on 
chemical properties.  For example, isotopic peaks or adducts can be automatically 
filtered to simplify analysis.  Finally, experiment level filters allow the user to select  
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Figure 5.  Visualization system overview (from Grigsby et.al. 2010). 
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items related to the biological experiment such as treatments levels or longitudinal 
studies for analysis.  
 The filtered data is visualized through a variety of displays.  The displays allow a 
multifaceted view of the data.  Figure 6 demonstrates one series of filter-display 
interactions possible using the visualization system.  In this example, the main display 
opens with a view of all registered peaks stored in a summary table along with a heat-
map.  Each point in the heat-map represents the location of a registered set of matched 
peaks.  The position of the point in the heat-map denotes the peak-set’s average mass 
and average retention time. These correspond to the values of (Mavg, Tavg) shown in 
Figure 4D.  The brightness of the point is determined by the value of the most intense 
peak in the registered set (Imax in Figure 4D).  As shown in Figure 6, the user can apply a 
data filter to identify a smaller set of registered peaks for analysis and then alter the 
view to show line plots summarizing the behavior of several registered peaks.  The user 
can select a single registered peak, plot the behavior of all samples as a function of the 
experimental parameters (treatment vs time) and select a specific sample for further 
analysis.  Additionally, the user can explore the raw data in a 3D scatter plot with the 
ability to zoom-in and zoom-out in any specified spectral region. 
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Figure 6.  Example MVC (model-view-controller) interaction (from Grigsby et.al. 2010). 
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Results and Discussion 
 To illustrate the utility and power of MeDDL in the visualization of large, multi-
group experiments, we analyzed data from an LC-MS effort for profiling low level kidney 
biomarkers in the F344 rat model.  Importation of the raw QToF MS data files and 
subsequent analysis of the aligned and registered peak database by MeDDL identified 
numerous metabolic changes in the urine of the animals after D-Serine treatment 
compared to control animals.  Registration and processing of the D-serine exposure data 
(n=208) utilizing peak inclusion criteria requiring each m/z at a given retention time be 
present in a minimum of 5% of all samples was accomplished in 122 minutes.  A smaller 
sample set of n=20 was similarly registered and processed in 12 minutes to establish 
scalability, with all analysis performed utilizing a dual core 2.53GHz CPU with 6 GB of 
RAM.  This alignment and registration encompassed all detectable peaks, with absolute 
intensity values as low as 30 being registered (background level previously established 
by our group for the QToF Micro).  
 To verify the accuracy of the registration and analysis algorithms, a spiked study 
of control F344 rat urine was performed (Figure 7A) using a purchased metabolite test 
mixture of five known compounds (Waters Corporation Metabolomic Test Mix).  An 
artificial dose response was generated as shown below (Table 4) and examination of 
nortryptyline (m/z 264.1752), the highest intensity standard in this set, via Masslynx 
(Waters Corporation) generated the response illustrated in Figure 7B (below).  Following  
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Figure 7.  A – Spectra from spiked study of control F344 rat urine showing presence of 
nortryptyline in spiked urine, TIC of spiked urine sample, and TIC of neat test mixture 
utilized in spike.  B – Nortryptyline dose response obtained via Masslynx (Waters Corp.). 
C - Nortryptyline dose response obtained via MeDDL following alignment and 
registration.  D – Selection of nortryptyline via MeDDL as showing >5-fold change in time 
versus treatment (from Grigsby et.al. 2010). 
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 Theophylline Caffeine Hippuric  Acid 4-Nitrobenzoic acid Nortryptyline  
0 Hr 0 pg 0 pg 0 pg 0 pg 0 pg 
24 Hr 750 pg 750 pg 750 pg 375 pg 281 pg 
48 Hr 3.75 ng 3.75 ng 3.75 ng 1.88 ng 1.41 ng 
72 Hr 375 pg 375 pg 375 pg 188 pg 141 pg 
96 Hr 750 pg 750 pg 750 pg 375 pg 281 pg 
 
Table 4.  List of spiked standards (Waters Corporation Metabolite Test Mix) in F344 
control urine utilized in software validation study generating a synthetic dose response 
(from Grigsby et.al. 2010).  
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processing by MeDDL, nortryptyline was registered by the software generating an 
identical response curve to that manually determined in the vendor supplied instrument 
control software (Figure 7C).  Analysis of the spiked data utilizing the previously 
described fold change filter for all masses showing a 5-fold change across time for a 
given dose showed inclusion of nortryptyline (Figure 7D).  Accuracy in both the ability of 
the software to perform correlations as well as in peak registration can be 
demonstrated through correlation of adducts and isotopes in the aligned peak database, 
which also allows for their easy visualization and elimination as candidate biomarkers. 
 As described, twenty separate groups (4 doses x 5 time points) totaling 208 
samples were analyzed.  Following alignment and registration of the D-serine exposure 
data, more than 4000 isotopic peaks were originally registered and matched prior to 
automated de-isotoping via MeDDL.  During this process the isotopes were identified 
after peak matching was complete.  The location (Mavg,Tavg) of each synthetic peak was 
used to initiate a search for mono-isotopic peaks.  For a given peak, a search was 
conducted to located mono-isotopic peaks by looking for a peaks at location  
(Mavg + 1,Tavg) (Mavg + 2,Tavg) and (Mavg + 3,Tavg).  A match was found if a peak was located 
within the region defined by (Mavg + 1 ±Mε,Tavg±Tε) where Mε and Tε is a user specified 
limit on mass and retention time variation between isotopic peaks.  Once a potential 
isotope is identified, the intensity of the actual extracted peaks (main peak and isotopic 
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peak) in each image is compared to verify that the isotopic peak has a decreasing level 
of intensity.  If all peaks in the set and their corresponding isotopic peaks satisfy this 
requirement, the isotopic peaks are tagged and can be hidden / removed by the user.  A 
similar process is used to locate doubly and triply charge isotopic peaks and tag them for 
removal. 
 One of the novel aspects of the MeDDL peak alignment process is the use of a 
two stage process that begins with a rough peak match where only a few isolated peaks 
are identified between a reference image and each unregistered image.  These initial 
peaks are used to compute a polynomial transformation between the reference image 
and the unregistered image producing a rough alignment.  This is essentially a global 
process that handles systematic misalignment between images. In the peak matching 
phase, alignments are refined through a process similar to relaxation labeling [108, 109].  
After the rough alignment, a synthetic image is created by taking each image in turn and 
using every peak in the image as the center of a peak acceptance region.  Any peak in 
any other image captured within the acceptance region is matched to this peak.  The 
average mass and retention time (Mavg,Tavg) across the set of peaks is computed as 
(Mavg,Tavg).  Initially, the acceptance region is very small so peaks that were not well-
aligned by the polynomial function will not be matched.  The relaxation process slowly 
opens the size of the acceptance region to attempt to draw in one peak from each 
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image.  Each time a new peak is captured within the acceptance region, the average 
(Mavg,Tavg) is recalculated.  Thus, the acceptance region gradually shifts and coalesces to 
maximize the number of matched peaks across all images at the final value of 
(Mavg,Tavg).  This combination of global alignment / local refinement allows the matching 
to respond to both systematic misalignments as well outliers that appear as random 
variations within individual images.  Additionally, although MeDDL accurately aligned all 
data generated by our laboratory, the retention time variation observed with the 
Waters Corp. Acquity UPLC was minimal (<0.25 min).  As such, alignment was achieved 
through the use of a 2nd order polynomial and our two stage peak alignment process.  
During development, our group evaluated use of higher order functions; however, we 
deemed it unnecessary for our use.  This can be easily modified to be a user editable 
feature through the software interface if necessary for other chromatography systems. 
 During the analysis of the exposure data, two of the primary tools included in the 
MeDDL platform were utilized by our group, principal component analysis [110] (PCA) 
and a novel fold change filter.  The design of the fold change filter analysis is based on a 
multilevel statistical model that views the behavioral response (intensity) of each 
synthetic peak as a normally distributed random with the added assumption that the 
behavior of peaks within individual images is correlated.  Based on this underlying 
statistical model the system is designed to handle longitudinal data sets consisting of 
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subjects exposed to multiple levels of treatments.  The statistical models are designed 
to allow the user to perform statistical tests for significant differences between 
treatment levels, significant differences between treatment time points, or significant 
differences between any combination of treatment levels or time points.  In future 
applications, if other analysis tools become required, MeDDL is easily expandable 
through its use of the MVC software architecture previously described.  This software 
architecture allows a programmer to extend the functionality of the system as follows 
(1) add a new choice to any pull-down menu in system menu, (2) install a new callback 
for the menu item that invokes a user defined function, and (3) create a new user 
function (userFunction.m).  The user code added to userFunction.m has full access to all 
Matlab libraries (e.g. image processing, signal processing, pattern recognition, statistics, 
etc.) and full access to the summary data describing the matched peaks, the full 
description of every peak in a matched set and the raw data for every image.  This 
allows a programmer / user to add new functionality to the system without altering the 
existing functionality. 
 PCA was performed for all groups of study animals and is shown in Figure 8.  The 
PCA plot demonstrates clear separation between sample dosage and time groups with 
the majority of metabolomic changes in urine observed at 24, 48 and 72 hours post 
treatment with 500 mg/kg D-Serine.  The number of peaks that undergo at least a 2-fold  
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Figure 8.  A - Principal component analysis of LC/MS data for all experimental animal 
groups of the study. Legend is on the right of the figure. B - Principal component analysis 
of LC/MS data for 0, 5, 20 and 500 mg/kg doses at 24 hours only (from Grigsby et.al. 
2010). 
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change is 19 times higher for the 500 mg/kg dose than the 5 mg/kg dose, with the 
changes literally disappearing at 96 hours, most likely indicating kidney recovery.  
 At 24 hours post-dosing for the 500 mg/kg group, as many as 426 peaks show a 
greater than 2-fold change with the peak intensity cut-off set to a minimum of 100. 
Although the 2-fold increase was established based on our goals of identifying 
differential yet detectable metabolite biomarker profiles, the fold change filter 
incorporates detailed statistical analysis including ANOVA (1-way, 2-way and N-way) 
among the selected subject groups. The user can optionally perform multiple pairwise 
comparison tests among the means of groups to determine whether or not all 
differences among group means satisfy a user defined level of significance. A Bonferroni 
correction is applied to compensate for the tendency to incorrectly find a single pairwise 
significant difference among multiple comparisons.  Further, five metabolite peaks 
exceeded 100-fold change with the same intensity threshold.  It is worthy to note that a 
number of peaks exhibit a statistically significant change while their intensities are 
relatively low, with most of these peaks demonstrating negative changes in our analysis.  
Examples of negative and positive changes are shown in Figure 9.  We have excluded 
isotopic peaks in our data analysis; however, some percentage of differentiated peaks 
can be attributed to adduct acquisition by metabolites as well as water loss.  Thus the 
difference of 18 mass units between peaks 1569 and 1598; 952 and 246; 1642 and 1532;  
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Figure 9.  Examples of selected peak plots of negative (A) and positive (B) changes after 
500 mg/kg D-Serine exposure (from Grigsby et.al. 2010). 
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1697 and 1664; and 3277 and 42 strongly suggest a water loss with each set of ions 
eluting from the column concurrently.   
 Preliminary metabolite identification was performed, with a list of potential 
metabolites shown in Table 5.  Purchased metabolite standards were run under the 
same LC conditions followed by MS/MS as selected samples.  Matching retention times 
and MS/MS fragmentation data generally indicate the conclusive identification of a 
metabolite, which has been demonstrated in a candidate biomarker identified in this 
study, 3-indolylacetic acid.  The MS/MS spectrum of 3-indolylacetic acid along with a 
spectrum from rat urine samples is shown in Figure 10.  This figure also demonstrates 
the ability of the MeDDL to automate spectral normalization.  In MeDDL, normalization 
begins by computing the mean (m1, m2, m3,…) and standard deviation (s1, s2,s3, …) of the 
values of all subjects in each treatment group at the first time point.  The peak intensity 
value ps(t) for each subject s in group j at time t is then normalized as: (pi(t) - mj) / sj.  
This effectively shifts all the plots so the mean value of the first time point in each 
treatment group is zero (see Figure 10C). 
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Table 5.  List of potential metabolites (shown as m/z) identified in urine of rats after 500 
mg/kg D-Serine exposure at 24 and 48 hours after the exposure.  Fold change filter set 
at 10 fold and higher (from Grigsby et.al. 2010).  
m/z Retention Time
Treatment x Time p-
value
521.2412 9.071536 3.31E-05
523.2543 10.508634 8.04E-05
491.2421 7.5071826 1.44E-04
501.2701 9.916751 1.74E-04
714.1853 1.6265737 2.22E-04
611.3051 10.67593 2.60E-04
609.2873 9.332852 5.72E-04
567.2799 10.59735 7.30E-04
613.3242 11.733243 9.17E-04
383.1925 4.111277 0.00169446
779.352 1.4149536 0.00176583
290.1256 1.469668 0.00190476
655.3292 10.74838 0.00203854
435.159 10.100951 0.00356158
589.3217 10.138795 0.00407047
479.2284 10.405753 0.0055822
701.3726 11.777291 0.00567922
326.1946 9.491132 0.00787954
553.2582 4.0478706 0.01769215
633.3461 10.232473 0.01919617
212.1025 1.1299926 0.02197477
330.0621 2.3208911 0.02478929
533.1005 4.628623 0.04081653
511.2622 4.253147 0.04097449
290.1258 1.7111521 0.04116634
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Figure 10.  Identification of a selected metabolite. Retention times and MS/MS 
fragmentation of 3-Indolylacetic acid is shown for standards along with corresponding 
ms/ms from D-Serine urine samples in A. Not normalized (B) and normalized (C) plots 
show changes for 3-Indolylacetic acid throughout the course of D-Serine study (from 
Grigsby et.al. 2010). 
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Conclusions 
 The data clearly demonstrate dramatic changes in the urinary metabolic profile 
in response to the kidney toxicant, D-Serine.  A list of potential metabolites 
corresponding to masses identified in urine of rats is presented.  D-Serine metabolomic 
profiling demonstrates that most changes occur between 24-72 hours.  The most 
dramatic changes occur at the 24-hour time point after exposure to 500 mg/kg D-Serine.   
The data suggests that near-normal kidney function resumes at 96 hours.   
 Although the ability to visualize the experiment at all levels may constitute the 
authors’ ideal for biomarker discovery and differential metabolite analysis, we feel it 
adds considerably to this effort by allowing the user to differentiate metabolite profiles 
in a large time-dose study while maintaining the ability to focus on individual 
metabolites and spectra for subsequent identification.  Additionally, although the tool 
performed quite well for LC/MS dose response study analysis, some early limitations 
were identified in the prototype version of the tool, principally the ability analyze data 
obtained via GC/MS.  GC/MS data presents a specific set of challenges, primarily due to 
differences in the ionization technique utilized. To address these challenges as well as 
implementing several marked improvements to the tool, significant changes to the 
prototype software were completed, as described below.  
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CHAPTER 4.  GC/MS FUNCTIONALITY AND EXPANDED TOOLSET  
 
Overview 
 As stated in Chapter 1, a growing body of discoveries in molecular signatures has 
revealed that volatile organic compounds (VOCs), the small molecules associated with 
an individual's odor and breath, can be monitored to reveal the identity and presence of 
a unique individual, as well their overall physiological status. Given specific analysis 
requirements for differential molecular profiling via gas chromatography/mass 
spectrometry, our group has expanded on the prototype Metabolite Differentiation and 
Discovery Lab (MeDDL) tool to allow for processing of VOC data [89].  Preliminary 
analysis via the MeDDL toolset generally identifies a moderately large number of 
differential, registered peaks, which, depending on filtering and comparison parameters 
could be in the range 50-100 peaks separating  the conditions of interest.  This initial, 
down-selected subset of peaks is typically too large for incorporation into a portable, 
electronic nose based system in addition to including VOCs that are not amenable to 
classification; consequently, it is also important to identify an optimal subset of these 
peaks to increase classification accuracy and to decrease the cost of the final system. In 
this chapter, we will discuss an approach to how this differential peak subset and their 
corresponding intensities are used as features for classification.   
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 As the first illustration of our approach to these studies, we present the below 
urine based VOC comparison of the two parental strains of the BXD mouse model [111], 
C57 and DBA.  For this comparison, we demonstrate the expanded MeDDL functionality, 
to include machine learning tools via a classifier similar to a K-nearest neighbor (KNN).  
This modified KNN classifier is used in conjunction with a genetic algorithm (GA) that 
simultaneously optimizes the classifier and subset of features.  The GA utilizes receiver 
operating characteristic (ROC) curves to produce classifiers having maximal area under 
their ROC curve.  Using this approach, experimental results shown below on over a 
dozen recognition problems show many examples of classifiers and feature sets that 
produce perfect ROC curves.   
  
Data Filtering 
 Following the spectral registration and alignment previously described [100], the 
data was analyzed using several of the principal analytical methodologies included in 
MeDDL: unsupervised clustering via principal component analysis [110]; differential 
down selection of peaks through combination of a set of logical filters; and utilization of 
machine learning based tools for significant VOC “feature” identification. 
 MeDDL was originally created for the analysis of LC/MS data.  The ionization 
techniques generally employed for LC/MS are termed “soft” and impart low energy to 
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eluting ions, resulting in fairly simple mass spectra: often comprised of just the ionized 
analyte, or “parent” ion.  Modifications to the original implementation of MeDDL were 
required to aid in the analysis of the more complex mass spectra in GC/MS resulting 
from the “hard ionization” induced by the electron impact (EI) fragmentation process in 
the mass spectrometer’s ion source.  A reductionist approach for this analysis was 
required for the efficient determination of changes observed between sample groups.  
To address this issue, we created a supplementary time-binning filter allowing the 
analyst to specify both a time window and lower bound threshold of peak intensities.  
The comparison then proceeds as follows: an averaged, composite image of each user-
defined comparative group is generated (i.e. the surface obtained from samples 
comprising each comparative group); the most intense peak from all groups is evaluated 
across all aligned images using a 0.1 minute window and 100,000 absolute (total ion 
count) threshold; once the comparison is completed, this “time slice” based upon the 
peak apex ± ½ of the specified time window is removed from further analysis and the 
next most intense set of peaks are compared.  An additional filter applied in the 
differential analysis of groups in this study included a fold change filter limiting results to 
only those peaks which demonstrated at least 2 fold or greater change in intensity 
between strains.  It must be noted that although the MeDDL tool contains a wide variety 
of implemented statistical filters for feature down-selection, we limited their use to only 
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the 2 filters listed to allow for optimal feature selection by the classifier.  Once both of 
these filters were applied to the grouped, global data set, a Boolean "AND" was added 
to the resulting filtered peak sets to identify the logical intersection, an approach similar 
to that used in generation of a Venn diagram.  These reduced data sets were then used 
for further classification described below.   
 
Classification 
 The filtered, numerical data sets, or feature vectors, produced by the 
preprocessing described in the previous section must be used to perform classification 
on unknown samples for optimal results.  However, performing classification with these 
features still presents several problems.  First, the filtered features include noisy, 
irrelevant features, despite the preprocessing steps taken to identify features that have 
both intra-class similarity and inter-class dissimilarity.  Second, the set of filtered 
features include those that are highly correlated and therefore are redundant.  These 
two observations suggest the classification system should produce a classifier, but 
should also down select the incoming feature set to a small set of cooperative features 
that are amenable to classification. 
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Modified K-Nearest Neighbor Classifier 
 The basic KNN is a two-class classifier that is often used in situations where the 
data distributions are generally unknown [112].  KNN training is performed by using all 
samples of the training data as labeled prototypes.  Unknown samples are classified by 
comparing the distance of the unknown sample to the k nearest prototypes, where k is a 
small user-defined integer (e.g., 3). In binary classification (i.e., -two class classification), 
choosing an odd value for k avoids a potential tie vote.  The method of computing 
distance with N-dimensional data is commonly done in two different ways: Euclidean 
distance and L1 norm, or Manhattan/Minkowski distance formula using p = 2. This work 
uses Euclidean distance, but the L1 norm appeared to provide similar results.  The three 
nearest prototypes then vote on the unknown’s class label.  Figure 11 illustrates this 
process in two dimensions.  In this sample, the training data contains 5 samples, which 
includes 3 positive samples and 2 negative samples.  The three closest samples to the 
unknown are S1, S3, and S4, with the majority those samples being positives; 
consequently, the unknown would be labeled as positive. 
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Figure 11.  Example data and plot of data (from Grigsby et.al. 2012). 
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 One unique objective of this work was to develop a classifier that has one or 
more parameters that control the classifier’s behavior. For example, it may be 
important to correctly classify positives, with an increased tolerance for false alarms. 
Conversely, it may be deemed acceptable to miss a couple positives, if the increased 
number of false alarms is kept small. The k parameter in the KNN classifier does not 
provide such a parameter. k simply denotes the number of voters and does not provide 
a way to increase/decrease the sensitivity toward the class boundaries. Further, the 
number of prototypes is typically quite small in biological studies and therefore 
modulating the number of voters would have limited utility.  
 For an appropriately configurable classifier, a ROC curve visually illustrates the 
possible tradeoffs between the rates of true positives and false positives. Figures 12a 
and 12b illustrate a typical ROC curve and the perfect ROC curve.  Figure 12a depicts the 
tradeoffs of a hypothetical classifier. The figure shows that the classifier has a 
parameter that can allow it to obtain a 0.75 true positive rate, while simultaneously 
having a false alarm rate of 0.25. Should the operational situation require 0.9 rate of 
recognizing true positives, the rate of false alarms would reach a predicted level of 
approximately 0.75. ROC curves are monotonically increasing. The perfect classifier 
would obtain a rate of 1.0 for positives with a false alarm rate of 0.0. This perfect ROC 
curve is shown in Figure 12b. 
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Figure 12.  ROC Curves. Figure 2a shows a typical ROC curve. Figure 2b shows the 
perfect ROC curve (from Grigsby et.al. 2012). 
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To provide for an adjustable parameter, the KNN’s decision rule is modified (Figure 3). 
Whereas, the basic KNN’s decision rule is to count the votes to the nearest k prototypes, 
the modified decision rule uses the distance value to influence its decision. This is 
approach assumes that being closer to a prototype indicates that it is more likely to be 
of that category. The definition for the modified KNN decision rule is as follows, where T 
is the configurable parameter and k is an integer > 0.  The classification rule takes the 
ratio between the total distances to the closest positive prototypes and the closest 
negative prototypes. If the unknown happens to be a positive, it is expected that 
posDistance would be small and negDistance would be large, producing a small value for 
ratio. By adjusting T to a small value, the criteria for declaring “positive” becomes more 
stringent, in that the unknown’s distance from the positives must be quite small while 
simultaneously its distance from the negatives must be relatively large. Conversely, 
setting T to a large value allows more samples to be classified as positives. In the 
extreme case, T = infinity, all unknown samples will be classified as positives. 
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Figure 13.  Modified KNN pseudocode (from Grigsby et.al. 2012). 
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Learning Algorithm for Feature Selection 
 After preprocessing, the set of filtered features is sent to the classification 
system.  As mentioned above, the potential exists for reducing this set to an even 
smaller number.  Ideally, this reduction would produce a less costly system and produce 
a subset of features that are more effective than using the entire set as a whole.  The 
ideal subset would contain features with general properties such as: mutual 
independence, inter-class dissimilarity, and intra-class similarity.  Rather than applying 
more filters to achieve this, our approach is to use the modified KNN classifier to assess 
the quality of a feature subset; where good subsets will provide good classification and 
poor subsets will not be very accurate. 
 The process of selecting a subset from a large set uses a sequence of 0’s and 1’s 
to represent the subset.  Here the bit positions containing a 1 or 0 indicate features to 
be included or excluded.  Figure 14 shows a diagram illustrating how one bitstring is 
used to down-select the features and how that down-selection affects the resulting data 
set that is fed to the KNN learning algorithm.  In this example, the bitstring happens to 
have three on-bits located at positions 2, 4, and 5, indicating that only features 2, 4, and 
5 are used and features 1 and 3 are ignored.  The down-selected data is then used to 
form the modified KNN. 
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Figure 14.  Reduction of Training Data. The topmost figure shows the entire set of data. 
The middle figure shows one bitstring produced by the GA. The bottommost figure 
shows the training data without the excluded features (from Grigsby et.al. 2012). 
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 A GA is a natural learning algorithm to apply to this problem [113, 114] since it 
operates on a bitstring.  The reader is referred to the text by Goldberg [115] for a more 
complete treatment of GAs. For our purposes, it suffices to say that the GA is a method 
for optimizing a sequence of 0’s and 1’s.  In order to achieve this, the GA requires a 
method for evaluating the quality of the sequence.  By assigning a numeric score to a 
sequence, and many other sequences, the GA navigates the search space to find 
sequences that are better than the ones it is currently is examining. 
 Leave-one-out (LOO) cross validation [112, 116] is a common method for 
estimating the quality of a classifier using only training data.  LOO iterates over all the 
training samples, where each sample is temporarily removed from the training set.  This 
smaller set is then used to train the classifier, which is then applied to the sample that 
was held out.  Ideally, the classifier will correctly classify the sample.  By repeating this 
process over all training samples, it is possible to assess the generality of the learning 
technique.  If the LOO algorithm shows solid performance over a large percentage of the 
samples, it can be assumed that the learning technique generalizes to truly unknown 
samples. 
 On each iteration of the LOO algorithm, the bitstring in question ultimately 
results in a KNN that is used to classify the sample temporarily removed. Instead of 
classifying the sample, the ratio between posDistance and negDistance is recorded.  The 
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set of ratios can be used to create a ROC curve that predicts the final system’s ROC 
curve, where the final system refers to the modified KNN that is obtained by using all of 
the training data.  The area under the predicted ROC curve is used as the bitstring’s 
evaluation score.  Naturally, a score of 1 corresponds to a perfect ROC curve, which 
indicates that the feature set forms an effective KNN classifier. 
 
Materials / Methods for Machine Learning 
 Animal use in this study was conducted in accordance with the principles stated 
in the Guide for the Care and Use of Laboratory Animals, National Research Council, 
1996, and the Animal Welfare Act of 1966, as amended. BXD mice parental strains (DBA 
and C57) utilized for this study were singly housed in metabolic cages which are 
approximately 9 cm in diameter and urine and feces were separated and isolated.  
Individual mouse urine samples were collected using 1 mL disposable transfer pipettes 
(Thermo Fisher Scientific) and placed in 2 mL Eppendorf Snap-Cap Microcentrifuge Safe-
Lock tubes.  The urine was then stored frozen at -80°C and thawed on ice prior to 
analysis. For the BXD VOC baseline set described, 170 individual samples representing 
the two parental strains (C57 N = 81, DBA N = 89), and six additional test samples (C57 N 
= 3, DBA N = 3) were processed by aliquoting 200 uL of urine into a 10 ml crimp-top 
headspace vial (National Scientific).  The vials were immediately crimped with Red 
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PTFE/white silicone crimp seals (Fisher).  The bench-top GC/MS system utilized for 
sample analysis was a Thermo Fisher Trace GC Ultra gas chromatograph interfaced to a 
Thermo Triplus autosampler configured for automated SPME headspace sampling and 
in-line with a Thermo DSQII single quadrupole mass spectrometer.  Collection of organic 
volatiles from the urine was accomplished using a 2cm CAR/DVB/PDMS solid phase 
micro extraction fiber (SPME), Supelco supplier, inserted by the Triplus autosampler into 
the head-space of the sample vials.  The headspace samples were incubated at 60°C for 
15 minutes, followed by extraction at 60°C for 30 minutes and automated direct 
injection.  Volatiles gathered by the SPME fiber were analyzed through desorption of the 
fiber by heating to elevated temperature and separation with a Restek Stabilwax 30m, 
0.25mm ID column.  Helium was used as the carrier gas at a flow-rate of 1.5 ml/min.  A 
narrow bore SPME injector liner (0.75 mm I.D.) was used (Thermo).  The following 
conditions were utilized for sample analysis: desorption for 2 min via a PTV injector held 
at 230°C; oven temperature program 50°C (4 min); 5°C/min to 230°C; hold 30 minutes 
giving a total run time of 70 minutes.  The DSQII MS transfer line was held at 230°C and 
the instrument was operated in positive scan mode from 41 to 400 amu.  The raw data 
was collected in centroid mode and the resulting chromatograms and mass spectra (raw 
files) were then converted to CDF format and subsequently analyzed through MeDDL.  
Due to the fact that SPME extraction is a competitive process leading to mutual 
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displacement from the adsorption sites between different analytes or analytes and 
matrix constituents, the results of this study as described report data semi-
quantitatively based on relative peak heights.  
 
Machine Learning Results 
 A total of 170 BXD parental urine samples (DBA and C57 “teaching set”) were 
collected and analyzed over a four month period with the six unregistered “unknown”, 
test samples utilized below acquired over 12 months later.  Following GC/MS analysis, 
CDF conversion, and MeDDL registration, the samples in the “teaching set” were filtered 
for a 2-fold change and time binned (0.1 min window, 100K absolute threshold 
minimum cutoff).  The filter results are shown in Table 1, with peakset 1 comprising all 
registered peaks, peakset 2 comprising time binning, peakset 3 comprising fold change, 
and peakset 4 the resultant intersection of the two applied filters.  This subset of 52 VOC 
features, or peaks, were first screen by PCA (Figure 15) to demonstrate group 
separation prior to analysis by the hybrid GA classifier.  Principal component analysis is a 
mathematical procedure that uses an orthogonal transformation to convert a set of 
observations of possibly correlated variables into a set of values of linearly uncorrelated 
variables called principal components.  This technique is often difficult in usage to  
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 Subset Parameter Size 
PkSet 1 All Peaks  2845 
PkSet 2 Time Binning Delta T: 0.1  Min Int: 1000000 293 
PkSet 3 Fold Change 2 500 
PkSet 4 PkSet 2 AND PkSet 3 Boolean AND 52 
 
Table 6.  BXD parental strain peak registration and peakset (PkSet) filter results (from 
Grigsby et.al. 2012).  
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Figure 15.  PCA of C57 and DBA filtered intersect (peakset 4) results (from Grigsby et.al. 
2012). 
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identify the individual subset of features responsible for group separation, but is quite 
useful as a screening technique as in Figure 15. 
 MeDDL offers users the ability to utilize several different types of classification 
methods and separately store the resulting output for classification of additional, 
unregistered unknowns.  These methods use a combination of pre-coded Matlab 
classifiers, Waikato Environment for Knowledge Analysis (WEKA) classifiers, and the 
novel, in-house developed hybrid GA classifier, implemented in Java and Matlab, 
described in this study (Figure 16).  The internal data classification allows users to teach 
the classifiers from peak sets generated using the tool.  The external data classification 
is currently designed to process both CDF format files and comma separated value files 
(.CSV).  All classification methods support classifying intensities or ratios of intensities 
though application of appropriate data filters.   
 In testing the hybrid GA for this study (Figure 17), setting k = 2, minimum 
features = 4, and maximum features = 10 provided both perfect classification of C57 
versus DBA for both the 170 teaching samples as well as the 6 “unknown” external 
samples. Reverse classification (DBA versus C57) using these same settings resulted in 2 
mis-classifications of the “unknowns” illustrating the need to optimize the GA settings 
for each classifier result.  
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Figure 16.  MeDDL tool machine learning implementation and GA settings  (from Grigsby 
et.al. 2012). 
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Figure 17.  Hybrid GA results. Vertical line is user adjustable slider to determine T 
threshold values  (from Grigsby et.al. 2012). 
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 Results of the hybrid GA classifier were comprised of 10 VOC “features”, which is 
the maximum features size allowed by the GA settings.  An example of one of the 
selected VOCs is shown in Figure 18.  In an focused biomarker study, each resultant 
peak would then be preliminarily identified through comparison to the National 
Institute of Standards and Technologies (NIST) 08 database and Wiley libraries and 
verified though expert, manual spectral analysis and comparison with purchased 
standards. 
 
GC/MS Functionality Conclusions 
 The MeDDL platform has been markedly improved from the original version, 
with streamlined analysis of multi-group comparisons through the addition of a more 
intuitive interface, the ability to dynamically alter group definitions and group 
comparative displays, and the creation of definable, group comparative graphics.  These 
changes in combination with the addition of machine learning approaches greatly 
enhance the capability of the tool and future applicability to studies requiring biomarker 
discovery for sensor and diagnostics applications.  In the following chapter, several 
other examples of the universal utility of the tool in support of various GC/MS 
differential profiling studies will be described. 
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Figure 18.  Boxplot of hybrid GA VOC feature output selected by classifier  (from Grigsby 
et.al. 2012). 
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CHAPTER 5.  GC/MS DATA PIPLELINE 
 
Overview 
 To best demonstrate that the application of the comparative algorithms, logical 
operators, and statistical filters implemented in the developed software tool allow for 
the efficient analysis of GC/MS based VOC profiling studies, a variety of studies were 
analyzed and presented below.  Some of these studies in particular presented unique 
data handling challenges and aided in identification of needed enhancements required 
in future, "real-world" applications described in the following chapter.  Analysis of these 
separate data sets also help provide validation of implemented algorithms with 
examples provided.  Experimental examples of application of the volatile analysis 
pipeline developed, illustrated in Figure 19, and described below include: 
characterization of both human and murine urine as it ages, human markers of age and 
ethnicity in axillary odors, and characterization of the binding between volatile ligands 
and murine major urinary proteins (MUPs). 
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Figure 19.  GC/MS Data Pipeline Utilizing the Metabolite Differential and Discovery Lab 
(MeDDL) Tool. 
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GC/MS Experimental Example 1:  Differential Binding Affinities Between Volatile Ligands 
and Urinary Proteins Due to Genetic Variation in Mice 
 A collaborative study was completed using the MeDDL tool with scientists from 
Monell Chemical Senses Center (Philadelphia, PA) to investigate the composition of 
bound and unbound VOCs on the mouse major urinary proteins (MUPs) of various 
inbred species.  This effort was part of an investigation on the nature of murine volatile 
and pheromone based signaling and is described in detail in Kwak, et. al., 2012 [117].  In 
short, a comparison of the binding affinities in pooled male urine samples from three 
different inbred mouse strains (B6, BALB/b and AKR) was completed by measuring the 
release of volatile ligands before and after denaturation of the MUPs via SPME based 
headspace concentration and GC/MS analysis.  The sample set analyzed consisted of 
pooled urine samples collected over a 10 day period, one from each of the individual 
mice in the experiment (N = 8 B6, 7 AKR, and 6 BAL/b mice respectively).  Raw spectral 
data of both intact and denatured murine urine was supplied by Monell along with 
associated metadata of the study group samples.  A sampling of the raw spectral data 
was first reviewed for chromatographic and spectral reproducibility across the major 
urinary peaks, and then for instrumental absolute baseline and peak intensities to be 
used for spectral registration and alignment.  All  data was then converted to netCDF 
format and aligned/registered via the MeDDL tool, resulting in a total of 1895 peaks.   
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Figure 20.  Principal component analysis of the GC/MS data for the six different groups 
(a) and for the intact and denatured groups (b) from Kwak et.al., 2012. 
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Following registration and alignment, the GC/MS data were analyzed by PCA and the 
fold change filter as described in Chapter 4.  Screening for group separation via PCA, 
shown in Figures 20a-b demonstrate clear separation between each of the six different 
groups as well as between intact and denatured groups, indicating that both strain 
difference and protein denaturation are important contributors to the unique volatile 
profiles.  To identify those peaks responsible for the separation observed via the PCA, 
we used a combination time-binning (due to EI fragmentation), tests for fold-change 
and statistical significance, and absolute intensity using the below parameter values.  
We restricted the fold-change to only those time windows which demonstrated two fold 
increased levels of change upon protein denaturation (positive change) within a 
specified time slice of 0.1 minutes and an intensity threshold of 300,000 absolute 
intensity (total ion count).  A test for significance between all comparisons was also 
completed using N-way ANOVA (P≤0.1), which included Bonferroni correction to 
compensate for the tendency to incorrectly find a single pairwise significant difference 
among multiple comparisons.  Results obtained from the three strain specific pair-wise 
comparisons of intact to denatured samples displayed the increased release in 49 peaks 
induced by protein denaturation in AKR, 26 in B6, and 36 in BALB/b, respectively.  Figure 
21 illustrates the changes in the release of ligands upon denaturation.  
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Figure 21.  Changes in the release of ligands upon protein denaturation in the urine 
samples derived from different mouse strains. The y axis indicates the absolute intensity 
of the base peak ion in each ligand. I: intact urine; D: denatured urine. The degree of 
release in each ligand was distinctive in each strain.  
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GC/MS Experimental Example 2:  Changes in Volatile Compounds of Mouse Urine as it 
Ages:  Their Interactions with Water and Urinary Proteins 
 A collaborative study was completed using the MeDDL tool with scientists from 
Monell Chemical Senses Center (Philadelphia, PA) to investigate changes in the volatile 
composition of mouse urine as it ages.  This effort was part of an investigation on the 
nature of murine volatile and pheromone based signaling and is described in detail in 
Kwak, et. al., 2013 [118].  In short, the amount of water in an aqueous sample influences 
releases of VOCs from the sample.  As the sample dries, evaporations of water-soluble 
VOCs accelerate, whereas the loss of water may render some VOCs to bind to solid 
surfaces, preventing them from being released into the air.  A number of studies 
measured the loss of VOCs as male mouse urine aged.  Some VOCs were removed 
rapidly, whereas others were released slowly.  However, the previous studies did not 
clearly demonstrate whether the gradual releases of the VOCs were due to their binding 
to MUPs and/or due to the loss of water as urine became dried.  In addition to the roles 
of water in the release of VOCs mentioned above, the loss of water in urine may alter 
the structure of MUPs, losing their ability to retain volatile ligands.  Here, we 
investigated the effect of water loss on the releases of VOCs while mouse urine dried, 
and determined whether the ligand-binding ability of MUPs in the dried urine remains 
active.  Using similar sample collection and GC/MS methodologies utilized in Kwak, et. 
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al. 2012, a data set comprised of 24 chromatograms were generated from a pooled 
collection of 4 - B6 male mice and 3 - B6 female mice acquired over several days by 
analysis of 12 aliquots of each sex pool.  These 24 aliquots (12 for male and 12 for 
female) were separated into 6 condition groups, giving an N=3 per treatment.  
Treatment groups consisted of "intact", "aged", "aged + water", and "aged + water + 
GdmCl" with each treatment described in detail in Kwak, et. al., 2013.  Raw spectral data 
was supplied by Monell along with associated metadata of the study group samples.  A 
sampling of the raw spectral data was first reviewed for chromatographic and spectral 
reproducibility across the major urinary peaks, and then for instrumental absolute 
baseline and peak intensities to be used for spectral registration and alignment.  All  
data was then converted to netCDF format and aligned/registered via the MeDDL tool, 
resulting in a total of 1166 peaks.  Following registration and alignment, the GC/MS data 
were analyzed by PCA and the fold change filter as described in Chapter 4.  Screening for 
group separation via PCA, shown in Figures 22, show clear separation between each of 
the treatment groups, indicating that sex, MUP denaturation, and hydration state are 
important contributors to the unique volatile profiles.  To identify those peaks 
responsible for the separation observed via the PCA, we used a combination time-
binning (t = 0.1 min) inclusive of only those peaks >200 K absolute intensity and tests for  
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Figure 22.  Principal component analysis of the treatment groups from showing clear 
feature separation. 
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Figure 23.  The number of binned peaks which displayed 2 fold or greater absolute 
intensity changes in each pairwise comparison (from Kwak et.al., 2013). 
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fold-change (≥ 2).  Once each of these filters was applied to the grouped, global data set, 
a Boolean “AND” was added to the resulting filtered peak sets to identify their logical 
intersection. fold-change (≥ 2).  Once each of these filters was applied to the grouped, 
global data set, a Boolean “AND” was added to the resulting filtered peak sets to 
identify their logical intersection, resulting in 142 compounds for further investigation 
(see Figure 23a-b), which is described elsewhere (see Kwak et.al. 2013).  
 
GC/MS Experimental Example 3:  Changes in Volatile Compounds of Human Urine as it 
Ages: Their Interaction with Water 
 A collaborative study was completed using the MeDDL tool with scientists from 
Monell Chemical Senses Center (Philadelphia, PA) to investigate changes in the volatile 
composition of human urine as it ages.  The urinary odors emitted from toilet facilities 
and from individuals suffering from either incontinence or metabolic disorders are 
perceived as unpleasant.  As anecdotal reports suggest that the odor of aged urine is 
different from that of fresh urine, using techniques described above for murine urine 
this study sought to identify the specific, differential VOCs released from aged human 
urine.  As described in Kwak et.al. 2013 [119], the urine samples analyzed consisted of a 
pooled sample collected from 6 adults (3males and 3 females).  From this pooled 
sample, six 1 mL aliquots were prepared, with each aliquot placed in a 60 mL glass jar 
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and capped. Three of the prepared aliquots were analyzed immediately via SPME based 
headspace concentration and GC/MS analysis and served as the "Intact" study group. 
The remaining three aliquots were left uncapped in a ventilated chemistry hood for 24h 
until nearly dried and served as the "Aged" study group.  Raw spectral data was supplied 
by Monell along with associated metadata of the study group samples.  As described 
above, a sampling of the raw spectral data was first reviewed for chromatographic and 
spectral reproducibility across the major urinary peaks, and then for instrumental 
absolute baseline and peak intensities to be used for spectral registration and 
alignment.  All  data was then converted to netCDF format and aligned/registered via 
the MeDDL tool, resulting in a total of 384 peaks.  To identify the differential VOCs, the 
following filter settings were used: the fold change filter was limited to those peaks with 
2-fold or greater change in intensity and the time binning filter parameter was set using 
0.1 min bins and inclusive of only those peaks >10K absolute intensity.  Once each of 
these filters was applied to the grouped, global data set, a Boolean “AND” was added to 
the resulting filtered peak sets to identify their logical intersection.  Results of the time 
binning filter generated 103 discrete peaks and combination with the fold filter (Intact 
vs Aged) resulted in 58 differential VOCs.  The 58 peaks were identified and a list of the 
identified VOCs is provided in Table 1 (from Kwak et.al. 2013). 
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Retention time 
(min) 
Base ion Compound ID Fold change (Intact -> Aged) 
1.32 42 trimethylamine* 5.05 
2.15 43 acetone 29.66 
2.90 43 2-butanone 17.43 
3.22 45 ethanol 11.71 
4.06 43 2-pentanone 51.83 
4.42 43 2-methyl-3-pentanone 13.17 
4.62 58 2-hexanone 8.19 
5.59 43 3-hexanone 11.04 
6.15 57 3-heptanone 32.95 
6.50 43 3-ethyl-2-pentanone 4.12 
6.88 43 3-methyl-2-hexanone 3.74 
7.39 43 4-heptanone 145.33 
8.86 43 2-heptanone 12.88 
9.36 43 3-methyl-2-heptanone 12.81 
9.57 57 6-methyl-3-heptanone 11.69 
9.82 69 3-methylcyclopentanone 14.45 
9.92 71 2-methyl-4-heptanone 5.42 
12.40 43 4-nonanone 2.42 
12.76 83 3-ethylcyclopentanone 22.58 
13.02 72 3,5-dimethyl-2-octanone 21.16 
13.92 58 2-nonanone 11.55 
15.68 43 4-hydroxy-2-pentanone* 2.17 
15.83 112 p-menthan-3-one 80.09 
16.06 60 acetic acid* 7.01 
18.44 45 propylene glycol* 14.58 
20.45 74 2-methylbutyric acid* 11.19 
20.50 60 3-methylbutyric acid* 3.26 
20.97 145 3,6-dimethylbenzofuran 15.88 
21.39 110 p-menth-1-en-3-one 32.04 
21.48 107 a terpene 31.94 
21.80 59 acetamide* 2.61 
22.77 42 caprolactone* 4.41 
24.58 79 dimethyl sulfone* 11.96 
26.78 71 pentolactone* 7.34 
27.47 107 p-cresol 6.59 
Table 7.  A list of the volatile compounds whose levels changed after the urine samples 
were aged [119].  (* indicates the compounds whose absolute intensities increased after 
the samples were aged.)  
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GC/MS Experimental Example 4:  Human Volatile Markers of Age and Ethnicity in 
Axillary Odor profiles 
 A collaborative study was completed using the MeDDL tool with scientists from 
Monell Chemical Senses Center (Philadelphia, PA) to investigate human volatile markers 
of age and ethnicity in axillary odor profiles.  Volatile organic compound biomarker 
discovery in humans is especially challenging due to significant variances in diet, 
environmental conditions/exposures, and genetics.  Thus, creation and validation of 
outlier filtering and normalization approaches for spectral data is required for the 
differential analysis of many studies involving human subjects, with four approaches 
evaluated for this study: Total Ion Current (TIC) based normalization; "Olympic average" 
based normalization; outlier filtering; and "Group Distribution" based filtering.  Please 
note that these are just a few of the filter types available in MeDDL, with a more 
complete listing available in Appendix A.  In short, TIC normalization involves summing 
the intensities of all peaks contained in each file of the spectra and setting that sum as 
equal across all files.  This approach, however, can be skewed by the presence of high 
intensity outliers, thus "Olympic average" based normalization was implemented.  In 
"Olympic average" based normalization, user defined upper and lower percentiles are 
calculated across all of the files using user defined values.  This will generate in two 
vectors containing percentiles, each with a size of n by 1, where n is the number of 
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features. These percentile vectors are used to normalize the intensity values for all ions 
across each file.  The difference of the original intensities in a file and the lower 
percentile value is divided by the difference of the upper and lower percentiles. This 
technique will scale down the intensities by several orders of magnitude, but should be 
less susceptible to the presence of low/high intensity outliers.  Next, the outlier filter, 
using an operator defined threshold, removes those peaks that are outside of the range 
of the n number of standard deviations from the mean.  The user specifies the number 
of standard deviations to accept and data outside of this range will not be shown 
throughout MeDDL (i.e. this is a display filter, not a data exclusion filter).   It should be 
noted that as this filter replaces excluded data points from the display with NaNs ("Not a 
Number"s), some comparisons and plots, such as PCA, cannot be generated using the 
modified data set.  The final filtering technique evaluated, and the one utilized for study, 
is a similar mean distribution filter to the "outlier" display filter labeled "group 
distribution" as currently implemented in MeDDL.  In this filter, the means and standard 
deviations are calculated across all files for each peak.  Each value is checked to ensure 
that it is within the user-defined number of standard deviations from the mean, and if 
the peak is more standard deviations away then the given threshold, the peak is 
excluded from the final peak set. 
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 In brief, for sample generation by Monell scientists, body odors were collected 
from 40 female subjects consisting of N=10 of four ethnic and age group (Young 
Caucasian, Young Asian, Older Caucasian, and Older Asian) under a protocol approved 
by the University of Pennsylvania Institutional Review Board.  Subgroups of these 
extracts were combined to form super-donors to eliminate sensory panelists focusing on 
individual donors.  Prior to skin extraction, subjects were screened via collected SPME 
samples prior to formation of super-donors to insure that no donor was an outlier (e.g., 
unusual VOCs such as bromoform from swimming pool water).  The raw GC/MS data 
from these collected samples was supplied by Monell along with associated metadata of 
the study group samples.  As described above, a sampling of the raw spectral data was 
first reviewed for chromatographic and spectral reproducibility across the major peaks, 
and then for instrumental absolute baseline and peak intensities to be used for spectral 
registration and alignment.  All  data was then converted to netCDF format and 
aligned/registered via the MeDDL tool to look at inter-age and inter-ethnicity variation 
in skin VOCs. 
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Figure 24.  Outlier Filter Example.  The figure on the top was generated  using the 
original data and the figure on the bottom was generated after the outliers were 
removed.  A setting of 1 standard deviation was used in this case. Notice the difference 
in scale between the two images.  
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 A total of 2960 peaks were registered.  To identify the differential VOCs, the 
following filter settings were used: the fold change filter was limited to those peaks with 
2-fold or greater change in intensity and the time binning filter parameter was set using 
0.1 min bins and inclusive of only those peaks >100K absolute intensity.  A minimum 
threshold hold filter was also applied to include only those peaks exceeding an absolute 
intensity threshold as low level, trace compounds were not considered relevant to the 
funding sponsor (deodorant manufacturer).  Next, the group distribution filter, 
described above, as applied and excluded all peaks > 3 standard deviations from the 
group mean.   Once each of these filters was applied to the grouped, global data set, a 
Boolean “AND” was added to the resulting filtered peak sets to identify their logical 
intersection.  Results of the each of the respective filters are shown below, and the 
resulting intersection indentified  55 differential VOCs.   
PkSet 1 - All Peaks - Size: 2960  
PkSet 2 - P-Value <= 0.1 - N-way - Size: 2063  
PkSet 3 - Time binning - Delta T: 0.1 Min. Int.: 100000 - Size: 419  
PkSet 4 - Fold Change of 2 - Size: 2123  
PkSet 5 - Group Intensity Filter of 300000 - Size: 785  
PkSet 6 - Group Distribution Filter of 3 - Size: 332  
PkSet 7 - Pkset 2 AND PkSet 3 AND PkSet 4 AND PkSet 5 AND PkSet 6 - Size: 55 
 
Results of principal component analysis and unsupervised hierarchical clustering of this 
filtered data set are shown in Figure 25 and demonstrated definitive separation 
between Asian and Caucasian older age group females.  
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Figure 25.  Filtered Data from Age and Ethnicity Based Skin VOC Differences. 
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Conclusions 
 Given the unique requirements for the various GC/MS based biomarker studies 
described above, comparative analysis, via MeDDL has facilitated efficient of each and 
successfully demonstrated not only application and utility of the expanded GC/MS 
functionality but also the versatility of the approach.  This described methodology is 
representative of our analytical pipeline and is applicable to a wide range of VOC and 
small molecule based differential profiling and biomarker discovery applications such as 
human performance monitoring, odor based biometrics, medical diagnostics, targeted 
materials detection, and environmental health and safety investigations, some of which 
will be addressed in the following chapter. 
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CHAPTER 6.  COMPREHENSIVE SAMPLING PIPELINE 
 
Overview 
 As addressed earlier, studies which require complete characterization of an 
unknown, whether it is biologically derived, such as human breath, or environmental, as 
in the case of fighter cockpit air, necessitate varied approaches to collection for accurate 
and broad-spectrum capture of all potential molecular species present.  To address 
study requirements for work performed by our laboratory and to complete the end-to-
end analytical pipeline which was the focus of this research, several "real-world" sample 
collection methods were developed and implemented for human breath capture as well 
as characterization of the in-flight, pilot air supply in operational combat aircraft, one of 
which is presented below.  As covered in chapter 1, a variety of methods are available 
for volatile sampling.  To be able to both quantitate obtained samples and to increase 
the likelihood of isolating potential environmental contaminants, thermal desorption 
tube based approaches were selected with follow-on analysis being completed utilizing 
a modified version of EPA Method TO-17 for monitoring VOCs [120], described below. 
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In-Flight Air Quality Sampling 
 Our laboratory supported investigation of reported issues surrounding the On-
Board Oxygen Generating System (OBOGS) utilized on the F22 and other USAF fleet 
aircraft.  As part of this effort, a technical solution was developed by our group to 
sample and analyze both the cockpit ambient air and OBOGS product air.  This involved 
placing thermal desorption (TD) tubes in line with the summa canisters already planned 
for placement into the OBOGS product line and into the cockpit air.  This solution 
allowed for a much more complete picture of the chemical make-up of contaminants in 
the oxygen supply and cockpit air.   The TD tubes provided the ability to capture and 
analyze heavier molecular weight chemicals (semi-volatiles) that the summas cannot be 
analyzed for.  The summas were still necessary to test for very light organics such as 
freons and inorganics such as oxygen (O2), carbon monoxide (CO), and carbon dioxide 
(CO2).  The summas, when timed with a critical aperture, also provided the airflow 
through the TD tube so that a known volume was collected for concentration 
quantification while avoiding the need for additional connections and equipment to pull 
air through the tubes (see Figure 26).  Empirical validation of this sampling strategy 
showed that a 1 hour collection using the summa canister as a passive pump in line with 
the TD tube resulted in a 400ml total volume collection for both.  This value was used to 
establish corresponding calibration curves for quantitation of detected compounds. 
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Figure 26.  Air sampling strategy for in-flight collection.  Top figure describes airflow 
through the TD tube and summa canister.  Bottom figure shows engineered solution for 
collection of both cockpit ambient air and OBOGS product supply to pilot. 
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 As stated above, all TD tubes were analyzed using a modified version of 
Environmental Protection Agency (EPA) method TO-17  for the determination of toxic 
organic compounds in ambient air using active sampling.  GC/MS analysis conditions are 
listed as follows.  TD100 TD auto-sampler parameters: cold trap low temp.: 15°C; Tube 
desorption temp.: 310°C; tube desorption time: 10 min; trap purge time: 1.0 min; cold 
trap high temp: 315°C for 5 min; split ratio: split-less; trap heating rate: 40°C/s (MAX); 
TD flow path: 160°C.  Thermo GC Ultra parameters: carrier gas: He; DB-624 column: 60 
m x 0.32 mm x 1.80 μm; constant pressure mode: 10 psi; temp. program: 40°C (1 min), 
10°C/min to 240°C (20 min) . Thermo ISQ conditions: MS source temperature: 275°C; 
transfer line temperature: 230°C; full survey scan mode mass range: 35 to 550 amu. 
Daily quality assessment/control procedures involved running a blank with internal 
standard and passing tune criteria for bromofluorobenzene (BFB).  The internal standard 
is a 4 component mix composed of two internal standards (1,4 difluorobenzene and 
chlorobenzene-d5), a surrogate (bromochloromethane), and a tuning compound 
(bromofluorobenzene).  Additionally, prior to processing samples, a laboratory control 
sample (LCS) and calibration check verification (CCV) were completed at the mid-point 
of the calibration curve.  The mid-point calibration curve was 25ppbv.  The LCS criterion 
is ± 30% of 25ppbv (17.5 – 32.5 ppbv). 
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  A two pronged approach was used for data analysis. First, a commercial Thermo 
Scientific software product, Tracefinder Environmental, Food, and Safety (EFS) version 
2.1 was used to store calibration results and generate quantitative/qualitative reports of 
TO-17 chemicals detected on the sorbent tubes.  This is performed by either matching 
sample peaks against a user generated library and calibration curves using a 
combination of retention time, quantitative ion, and confirming ions, or as an 
 unknown/tentatively identified compound via automated NIST11 search.  The limit of 
detection (LOD) established for most of the TO-17 compounds was established by our 
laboratory at 2ppbv.  All reports generated by Tracefinder were exported and 
summarized into Excel spreadsheets for data consolidation using an in-house Visual 
Basic software macro. 
 The second approach to data analysis was completed through use of the MeDDL 
tool (described above).  Following registration and alignment, the defined experimental 
result groups were processed through a logical combination of the three following data 
filters:  fold change limiting results to only those peaks which demonstrated at least 2 
fold or greater change in intensity; N-Way ANOVA with only those peaks having p < 0.1 
significance between groups; and the time binning filter using 0.1 minute bins inclusive 
of only those peaks > 200K absolute intensity. Once each of these filters was applied to 
the grouped, global data set, a Boolean "AND" was added to the resulting filtered peak 
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sets to identify their logical intersection.  These reduced data sets were then used for 
further manual, statistical, and machine learning comparisons and subsequent 
compound identification. 
 A total of 116 sorties were flown using this sampling strategy with 65 sorties 
completed at Langley/Hunter Air Force Base (AFB) and 51 sorties at Joint Base 
Elmendorf Richardson (JBER).  Note that the majority of the 65 sorties were flown from 
Langley AFB.  Each sortie generated a set of summa canister and thermal desorption 
tube data for both cockpit and OBOGS air samples (Figure 26).  Summa canister samples 
were analyzed using EPA TO-15 method by Columbia Analytical (ALS-Columbia) located 
in Simi Valley, CA.  Although specific data is not available for public release, these 
investigations identified trace amounts of chemicals in the system, none of which were 
above known hazardous concentrations, and were what was expected based on 
laboratory testing of the system’s ability to remove contamination.  Follow on studies 
are planned to determine if the chemicals and concentrations measured are typical 
among different fighter airframes vs. those collected and will provide a further 
understanding of fighter aircraft air quality baseline.   
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Figure 27.  Example of in flight data analyzed using the MeDDL tool. Samples consisted 
of 414 charcoal filters analyzed by thermal desorption (modified EPA TO-17). 
  
Same Sample Subset 
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CHAPTER 7.  CONCLUSIONS AND FUTURE DIRECTION 
 
Informatics Pipeline 
 Through a combination of the base MeDDL registration and alignment 
algorithms and the described additional functionality, MeDDL now offers the analytical 
chemist the potential for visualizing data in new ways, providing novel insight into the 
experimental results, and expediting LC/MS and GC/MS based biomarker discovery.  
Modifications to the current implementation of the tool are on-going, with automated 
iteration across available “unknowns” for optimization of the hybrid GA parameter 
settings planned.  The overall framework was rapidly prototyped using MathWork's 
Matlab software language and is being translated to the general purpose, platform 
independent language, Python, to support wide dissemination of the tool.  The MeDDL 
tool dramatically reduced manpower costs in our research by providing scaffolding for 
the rapid development and verification of new algorithms without the need to create a 
large amount of supporting software.  MeDDL also offered the potential for staff 
scientists to visualize data in new ways, providing novel insight into the experimental 
results and facilitating metabolomic biomarker discovery.  It should be noted that a 
number of tools have recently been proposed in the literature which show great 
advancements in metabolomic and LC-MS analysis capability [95-99, 121].  However, the  
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Figure 28.  Two phase system for compound identification and risk analysis. 
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Figure 1.  Two phase system for compound identification and risk analysis. 
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MeDDL tool, through its emphasis on visualization, provides unique opportunities by 
combining the following: easy use of both GC-MS and LC-MS data; use of both 
manufacturer specific data files as well as netCDF (network Common Data Form); 
preprocessing (peak registration and alignment in both time and mass); powerful 
visualization tools; and built in data analysis functionality. 
 A new effort to build on the success of the MeDDL tool has been initiated by our 
laboratory.  Portable GC/MS systems are currently deployed by the DoD in a variety of 
situations where the identification of the presence of various VOCs is required for 
protection of forces.  These systems rely on limited, build in VOC libraries and NIST 
reference spectra for identification of individual component compounds and are 
typically operated by personnel with minimal technical background.  Often times, 
materials of interest/concern are actually composed of complex mixtures, whose 
relative component ratios are the determining factor required for identification.  This 
research aims to enhance the capability of the fielded, portable GC/MS systems by 
providing rapid, on-site volatile signature recognition.  The prototype software system is 
envisioned as being composed of two cooperative sub-systems (Figure 28). The offline 
learning subsystem will be used in a laboratory setting to assemble an extensible library 
of labeled sensor features representing known volatile organic compounds. The labeled 
library of VOC’s will seed the second software subsystem; the online VOC analysis 
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system, capable of supporting real time analysis of unknown VOC’s captured using a 
field deployable GC/MS system.  Both subsystems will exploit algorithms and techniques 
developed as part of the MeDDL system described above as well as a probabilistic 
pattern recognition scheme previously utilized for processing synthetic-aperture radar 
data. 
 
Sampling Future Direction:  Exhaled Breath Collection and Biomarker Discovery 
 Screening for VOC’s in exhaled breath was an important tool during previous 
aircraft investigations support by our laboratory.  However, there were significant 
limitations in the assessment of the data as there were noteworthy levels of VOC’s 
observed in some incidents but it was not clear if those compounds were generated 
from physiological/ metabolic functions within an individual or from an environmental 
exposure that may have occurred during the flight.  Additionally, the summa canister 
based method previously utilized [122] for sample collection, while very useful for 
trapping and analysis of VOC’s with boiling points near that of naphthalene and below, 
is not capable of releasing higher molecular weight compounds which compose the 
majority of fuels/fluids utilized on aircraft.  On-going work by our group seeks to address 
the later of these concerns through both the characterization and evaluation of 
emerging and novel methodologies for breath collection (see Figure 29) as well as  
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Bag 1st tube 2nd tube MultiRae
Figure 29.  Gas bag and TD tube time series based breath collection methods 
currently utilized by our laboratory and collaborators for on-going breath 
biomarker discovery projects. 
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identification of breath markers of aviation relevant physiological states such as 
hypoxia, fatigue, and stress.    
 These on-going experiments by our laboratory and collaborators seek to expand 
the understanding and ability to detect the complex VOC profiles that are likely to be 
present physiologically, occupationally, and in the environment so that we are better 
able to monitor and protect personnel in the future.  The preceding, developed 
informatics tools and processing pipeline have created the foundation for these efforts 
and have provided our group a wonderful opportunity to successfully complete much of 
the work described.   
 
.  
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APPENDIX A.  SOFTWARE USER GUIDE 
Please note: a complete, online version of the MeDDL user guide is available at: 
http://meddl.cs.wright.edu 
 
Peak Data 
The Peak Data tab contains the main data table and will also serve as the location of any external 
data files that you load. For more information about loading external data, see the entry 
on External Data. 
Main Buffer 
This tab contains the main table that displays a summary of all of the registered peaks in a given 
data set. This table allows you to preform a variety of actions on any number of selected peaks. 
At the bottom of the table you will see a row of buttons that you will use to further analyze the 
data set. These include: Line Plot, Box Plot, PCA, Correlate, Data Table, and Copy. To find a 
peak in the Heat Map, simply right-click on it and a green circle will surround that peak. You also 
select multiple peaks and right-click on the selection to find multiple peaks in the Heat Map. 
Right-clicking once will only highlight peaks while you hold the right mouse button down. To lock 
highlighting around a peak, right-click twice. 
Line and Box Plot 
These plots will display a respective plot for each of the peaks selected. Be advised that you do 
not want to select too many peaks at one time because each plot will be displayed in a single 
figure. These buttons have two settings associated with them: Plot Display Group and Plot Color 
Group. These settings are defined in the Plot Filter tab. The Plot Display Group is the attribute 
that you wish to plot and the Plot Color Group is the attribute that you wish to use to split up the 
plots by. For example, if your data set has the attributes Strain (containing three possiblities: 
AKR, B6, and BALB_B) and MUP Protein (containing two possibilities: Intact and Denatured), 
then you can view a plot of the Strain versus MUP Protein by setting your Plot Display Group as 
Strain and Plot Color Group as MUP Protein. For a box plot this means that you will have two 
separate plots because you have two possible tags under attribute MUP Protein (Intact and 
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Denatured) with each containing three boxes along the x-axis (one for each of the tags under the 
attribute Strain). For a Line Plot this means that you will have one plot that has each Strain along 
the x-axis with each MUP Protein as a different marker. 
The Line Plot is unique in that it provides access to the raw spectra data for a particular peak. 
You may double click on any of the plotted points in a line plot. This will open a summary window. 
Click the Explore button to view a peak in the raw spectra. The window can be dismissed using 
the Done button. 
 
PCA 
The PCA button will generate a 3D plot of the prinple 
components in the data set as well as generate a 
variance pareto graph. The PCA uses the last two 
attributes in a given data set to generate labels. For 
example, if your experiment.ini file contains the 
following attributes: [File Subject Strain MUP_Protein], 
then you will have a PCA labeled with all possible 
combinations of the tags for the last two labels. Again, 
if the attribute Strain has three tags: AKR, B6, and 
BALB_b, and the attribute MUP_Protein contains two 
tags: Intact and Denatured, the PCA will have the labels: Denatured-AKR, Denatured-B6, 
Denatured-BALB_b, Intact-AKR, Intact-B6, and Intact-BALB_b. Note that you do not have to have 
any peak(s) selected to preform a PCA; the PCA is based off of the entire data set. 
Correlate 
The Correlate button will take a single selected peak and update the Rank column to contain a 
score for the correlation of the peaks in respect to the peak selected. The peak that was used to 
correlate from will have a score of 1.0. The correlate function will get the all of the intensities for a 
selected peak and pass them into the Matlab corr function. This will return a vector that is the 
same size as the main feature vector. This vector will contain Pearson product-moment 
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correlation coefficients for each of the comparisons against the selected feature, which will be 
from -1.0 to 1.0. See the corr function for more information. 
 
Data Table 
The Data Table button will display a table for the 
selected peaks that shows detailed information about 
the peak(s) across all of the samples/files. This 
detailed information includes data such as mass, 
intensity, and time. 
 
 
 
 
 
 
 
Group Filter 
The group filter tab allows users to create partitions and groups. For an explanation on partitions 
and groups, see the Data Management page. After users have created at least one group, they 
can begin to add groups to it. The All partition is a default partition that contains all of the files. 
Creating a Partition 
To create a partition, simply type a label in the partition text box and click the 'Save Partition' 
button. After you create a partition it becomes the active partition on the group filter tab. This 
means that any groups you save will be saved within it. To change the active partition, change 
the selected partition in the partition combo box. 
Creating a Group 
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To create a group, you will need to have created a partition (see above). Once you have a 
partition, toggle the check boxes under each tag of your data that you wish to include in the 
group. Note that if only one field is selected under a given tag, MeDDL automatically inserts that 
field into the groups label. Once the check boxes are set for the group, click the 'Save Group' 
button. Remember that this group will be added to the active partition (whichever partition is 
selected in the partition combo box). You cannot save a group in the All partition. The groups 
within a partition must be mutually exclusive. 
 
 
 
Outlier Filter 
Summary 
Removes peaks that are outside of the range of the n number of standard deviations from the mean. This filter inhibits the 
use of the PCA functionality. Users specify the number of standard deviations to accept. Data outside of this range will not 
be shown throughout MeDDL. 
Pseudocode 
mu = mean(intensities) 
stand = std(intensities) 
   
for i = 1 : number of files 
  for j = 1 : number of features 
    if(intensities(i, j) < (mu(j) - (factor * stand(j))) || outlierInten(i,j) > (mu(j) + 
(factor * stand(j)))) 
      intensities(i, j) = NaN 
    end 
  end 
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end 
Factor is the user-defined parameter representing the number of standard deviations from the mean to accept. 
Theory 
The means and standard deviations are calculated across all of the files for each peak. Each value is checked to ensure 
that it is within the user-defined number of standard deviations from the mean.The figure on the left is was generated 
using the original data and the figure on the right was generated after the outliers were removed. A setting of 1 standard 
deviation was used in this case.  
 
Total Ion Current (TIC) Normalization 
Summary 
Total Ion Current Normalization involves summing the intensities contained in each file of the 
spectra. The user selects which file to use as the seed file. The seed file will be used to build the 
normalization ratio. 
Pseudocode 
function computeTICs 
  TICs = [] 
   
  for i = 1 : number of features 
    TICs = [TICs; sum(intensities(i, :))] 
  end 
  return TICs 
end 
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TICs = computeTICs 
normailizationRatio =  seedTic / TICs 
  
for i = 1 : number of TICs 
  intensity(i, :) = normailizationRatio(i) * intensity(i, :);    
end 
Theory 
As you can see in the above pseudocode, a TIC score is calculated for each file in the data by 
summing the intensities in said file. This array of TIC scores is returned to a different function that 
applies the normalization to the data. The seed TIC is simply the TIC score from the file that the 
user selects in a drop down box. The TIC vector becomes the right division of the seed TIC and 
TIC vector. That is, each score in the TIC vector becomes the seed TIC divided by the original 
TIC score. Note that this makes the normalization ratio for the seed file to be 1; the intensities in 
the seed file will remain unchanged. The normalization ratio is applied to all of the intensities 
within each file. 
Olympic Average Normalization 
Summary 
The upper and lower percentiles are calculated for all of the features across each file. These 
percentiles are then used to normalize the intensity values in each file. Intensity values that 
become negative as a result of the normalization are replaced with NaNs. 
Enter the upper percentage and lower percentage in the respective text boxes. A setting of 90 
and 10 (as shown at the top of this page) will calculate the 10th and 90th percentiles. Thus, the 
data will be normalized using the upper and lower 10% of the data. 
  
149 
 
Pseudocode 
lower_percentile = prctile(intensity, lower, 2) 
upper_percentile = prctile(intensity, upper, 2) 
     
for i = 1 : number of files 
  normalizedIntensity(i,:) = (intensity(i,:) - lower_percentile(i)) / 
(upper_percentile(i) - lower_percentile(i)); 
end 
It is understood that the variables lower_percentile and upper_percentile can be 
calculated in one line. For example, the following command would return an array containing the 
upper and lower percentiles: prctile(intensity, [lower, upper], 2) Here we break 
them up for simplicity. 
Theory 
The upper and lower percentiles are calculated across all of the files using the user defined 
values. This gives us two vectors containing percentiles, each with a size of n by 1, where n is 
the number of features. These percentile vectors are used to normalize the intensity values for 
across each file. The difference of the original intensities in a file and the lower percentile value is 
divided by the difference of the upper and lower percentiles. This technique will scale down the 
intensities by several orders of magnitude. 
Consider the following Line Plots for the same peak. The left plot shows the original data and the 
right plot shows the data that has been normalized using the Olympic Average Normalization 
technique. The upper bound of the y-axis for the unnormalized data is 12 x 10^8 and the upper 
bound of the y-axis for the normalized data is 350. 
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Data Filter 
The Data Filter tab contains all of the filtering methods that allow you to down select your data so 
that you can focus on significant data. These filters create objects called peak sets. A peak set 
can be viewed in the Visualization Tab or classified in the Machine Learning Tab. 
P-Value Filter 
Summary 
The P-Value filter checks for statistical significance using ANOVA, calculating a p-value for each 
peak in study. After the p-values are calculated for each peak, a new feature vector is produced 
using the user defined p-value threshold (confidence bounds). This feature vector is saved as a 
peak set. 
Theory 
There are two options for the P-Value filter: 
 N-Way: performs an n-way ANOVA using the Matlab function anovan which accepts all of 
the groups in the active partition. The features are down selected to be only from files that are 
included in the active partition. The down selected features are sent to anovan. Thus, 
features from each file are compared to features from the remaining files. 
 Pairwise: performs a pairwise ANOVA using the Matlab function anovan iteratively 
generating all possible combinations of the groups in the active partition. The indices of the 
comparisons relate to the indices of all nonzero elements in a strictly upper triangular matrix, 
i.e. 1 to 2, 1 to 3, 2 to 3, etc. Groups are not compared to themselves. 
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Time Binning Filter 
Summary 
The Time Binning Filter allows you to reduce GC-MS data that contains fragments caused by 
electron impact. 
Pseudocode 
while sum(maxIntensities > 0) 
  maxIndex = max(maxIntensities); 
   
  intensityLogical(maxIndex) = 2; 
  maxIntensities (maxIndex) = 0; 
   
  timeCenter = timeAvg(maxIndex); 
  upper = timeCenter + (deltaT / 2); 
  lower = timeCenter - (deltaT / 2); 
   
  index = find( intensityLogical == 1 AND timeAvg >= lower AND timeAvg 
< upper); 
  intensityLogical(index) = 0; 
  maxIntensities(index) = 0; 
end 
Theory 
The Time Binning Filter drills down on the data set starting with the most intense peak of the data 
set. After the maximum peak is found, the peaks with times within ±t/2 from the time t0 are 
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removed from the data, where t is the user defined time parameter and t0 is the time of the most 
intense peak in the data set. This process is repeated until all peaks are processed. 
The intensities in the 'maxIntensity' array are set to 0 as the data is processed to indicate that 
they are of no further interest. The array 'intensityLogical' is a pseudo-boolean array. 0's indicate 
features of no interest, 1's indicate potential interest, and 2's indicate an intensity index that is the 
maximum within the time window. 
Fold Change Filter 
Summary 
The Fold Change Filter takes the average of each feature across all of the files that are included 
in a partition. This produces a group average vector for each group. The average vectors are 
divided by each other using right division, left division, a combination of both to produce a fold 
value vector (containing a fold value for each feature). Features with fold values that meet or 
exceed the user-defined threshold are kept. 
Pseudocode 
  left  = B / A; 
  right = A / B; 
 
  if typeChange == absolute 
      result = left >= foldChange OR right >= foldChange; 
      value = max(left, right); 
  else if typeChange == positive 
      result = left >= foldChange; 
  else 
      result = right >= foldChange; 
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Theory 
The components of the resulting fold vector are compared to the threshold that the user defines 
and only those features that meet or exceed the threshold pass the filter. If there are more than 
two groups in the active partition, then pairwise comparisons of all of the groups are generated. 
As in the ANOVA filter, the indices of the comparisons relate to the indices of all nonzero 
elements in a strictly upper triangular matrix. The disjunction of all of the feature vectors from 
each of the pairwise comparisons is generated: features must meet the fold criteria in at least one 
fold comparison. 
The Fold Change Filter has the options to accept only positive or only negative folds that fulfill the 
threshold, where a positive fold is defined as the right division of A and B and a negative fold is 
defined as the left division of A and B. Note: we define left division as B(i, j) / A(i, j) and 
right division as A(i, j) / B(i, j). See MathWorks for more information. The default setting 
is absolute, which accepts a feature if either the left division or right division is greater than the 
set threshold. In the case of the absolute setting, the resulting fold value vector will contain the 
maximum fold change from either the left division or right division of the average matrices. 
 Absolute: Calculate the fold using both the left and right division of the pair of matrices. The 
fold value will be the maximum for that feature from either matrix. 
 Positive: Calculate the fold using the right division of the average vectors. 
 Negative: Calculate the fold using the left division of the average vectors. 
 
Group Intensity Filter 
Summary 
The Group Intensity filter peaks that have an average intensity greater than the set intensity. 
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If 
Strict is used the conjunction of the feature vectors is taken to produce the final peak set. 
Otherwise, the disjunction of the feature vectors is taken to produce the peak set. 
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Pseudocode 
for all samples in the group on the filter tab 
   
  if strict is selected 
    remaining peaks = all the peaks AND peaks with an average intensity 
greater than the given absolute intensity 
   
  otherwise 
    remaining peaks = all the peaks ORpeaks with an average intensity 
greater than the given absolute intensity 
Group Distribution 
Summary 
Group Distribution filters out peaks that do not fall within the given standard deviation in the group 
it is contained in. If the peak is more Standard Deviations away then the given value the peak is 
excluded from the final peak set. 
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If 
Strict is used the conjunction of the feature vectors is taken to produce the final peak set. 
Otherwise, the disjunction of the feature vectors is taken to produce the peak set. 
Pseudocode 
for all samples in the group 
 
        upper limit allowed = group average plus the standard 
deviations 
        lower limit allowed = group average minus standard deviations 
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              if strict is selected on the filter tab 
         filtered peaks = filtered peaks AND intensities that are 
less than the upper limit allowed  AND intensities that are less than 
the lower limit allowed 
        
              otherwise 
         filtered peaks = filtered peaks OR intensities that are 
less than the upper limit allowed OR intensities that are less than the 
lower limit allowed 
   
Group Separation Filter 
Summary 
This filter compares all possible pair-wise combinations of the groups. The means of both groups 
are calculated, then the difference is found between the mean of every peak in each group. If the 
separation of that peak is larger than the given separation value then the peak passes the filter 
and depending on strict or loose may or may not be included in the final peak set. 
The Strict setting specifies whether or not all of the groups in the partition must pass the filter. If 
Strict is used the conjunction of the feature vectors is taken to produce the final peak set. 
Otherwise, the disjunction of the feature vectors is taken to produce the peak set. 
Pseudocode 
   for all possible combinations 
      setA = means for set A 
      setB = means for set B 
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      if strict is selected on the filter tab 
           filteredPeaks = filteredPeaks AND peaks that pass |setA - 
setB| > separationFactor 
      otherwise 
           filteredPeaks = filteredPeaks OR peaks that pass |setA - 
setB| > separationFactor 
Ratio Filter 
Summary 
There are two options for this filter, top heavy and singular. Top heavy squares the numerator of 
the equation used to find the ratios and singular does not. The filter calculates ratios based on a 
formula and returns the given amount of peaks with the highest ratios. The ratio is calculated by 
first generating all pair-wise combinations of the groups. Then the Standard Deviation and 
average intensities are calculated for each of those groups. Then the ratio is calculated by adding 
all the comparison combinations ratios together, ratios are calculate by the absolute value of the 
average of set one minus the average of set 2, intensity that is, divided by the standard deviation 
of set 1 times the standard deviation of set 2. The statistical significance would be finding peaks 
that are tightly formed and separated with respects to intensity. 
Top Heavy:  
Otherwise:  
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Pseudocode 
For all pairwise comparisons of the groups 
 
  setAMu = means of set A 
  setAStandardD = standard deviation of set A 
  setBMu = means of set B 
  setBStandardD = standard deviation of set B 
   
  if top heavy is selected on the filter tab 
    ratios = ratios + (setAMu - setBMu)^2 / (setAStandardD * 
setBStandardD) 
  otherwise 
    ratios = ratios + abs((setAMu - setBMu)) / (setAStandardD * 
setBStandardD) 
     
pick the n highest ratio peaks 
Mass-Time Exclusion Window 
Summary 
The mass-time exclusion filter allows you to specify an exclusion window of mass and time. This 
can be done in two ways: manually or with the heat map. To manually specify an exclusion 
window, enter the upper and lower bounds for both mass and time, and then click the Add button. 
This will add the window to the table on the right. You may now enter another window and add it 
to the table or click the Apply button to generate a peak set that excludes all of the windows listed 
in the table. To specify a mass-time exclusion window using the heat map, simply left click and 
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drag a selection box around the peaks that you wish to exclude. The coordinates (upper and 
lower bounds) of the selected region will be displayed in the text fields for the filter. You may click 
the Add button to add the window to the table or modify the upper and lower bounds by typing 
them in manually or by drawing a new selection on the heat map. 
 
Manual Selection 
Summary 
The Manual Selection Filter allows 
you to hand select peaks to be 
included in a feature vector. This can 
be used to include peaks of interest 
or to create a mask of peaks that are 
extraneous to your study. If the peaks 
are of interest, then you can view 
them as or logically OR them with 
another peak set. If they are 
extraneous, you can negate the 
feature vector and then AND the 
resulting peak set with any other peak set. 
Use the Select All/Deselect All to toggle all of the check boxes on or off, respectively. Use the 
toggle button to invert the state of all of the check boxes. Finally, the Apply button will generate a 
peak set from the selected peaks. All of the columns in the table support sorting, including the 
check box column. Left click on the column header to sort in the features in decreasing order. 
Click the header again to sort in nondecreasing order. 
Peak Set Editor 
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The Peak Set Editor allows you to manage peak sets. Use the delete button to delete a selection 
of peak sets. The Ctrl key allows you to select more than one peak set. The Delete All button will 
delete all of the peak sets. 
Machine Learning 
MeDDL offers users with several types of classification methods. These methods use Matlab 
and Waikato Environment for Knowledge Analysis classifiers. Each of these allow users to 
classify data that is internal or external to MeDDL. The internal data classification allows users to 
classify the peak sets that they have created using the tool. The external data classification is 
currently designed to process a comma separated value file (.CSV). All classification methods 
support classifying intensities or ratios of intensities. 
Matlab Tree Classifier 
 Greedy, sequential feature selection algorithm given by the sequentialfs Matlab function. 
 Uses a forward selection method (need to test the results of a reverse selection method). 
 If data has been filtered using the fold filter, the data will be sorted so that the fold values are 
in descending order. 
 User specifies the number of features to select and the number of folds for cross validation. 
 Allows the user to visualize the results by displaying a tree for the desired peak(s) or a bar 
graph of the peak(s). The tree is often a simple decision stump, but can have more depth to 
it. The bar graphs list the files along the x-axis and show the intensities for each file along the 
y-axis. 
Pseudocode: 
Initialize features vector to zeros 
while number of features is less than the requested number         
  Call the sequentialfs function 
    **The sequentialfs function uses the functions 
ClassificationTree.fit and predict to produce a classification score. 
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  Add the newly selected features to the features vector 
end 
As you can see, the sequentialfs method is very important in the classification method. It picks 
what features are important by adding them and seeing if classification performance is improved 
upon. Classification performance is generated by using the ClassificationTree.fit method. This 
method produces a tree. The tree is then used to classify the data using the predict method. The 
classifier’s labels are compared to the actual labels to produce a score. 
Matlab SVM Classifier 
 Same greedy, sequential forward selection algorithm as the tree classifier (sequentialfs). 
 Uses the svmtrain Matlab function. 
 Allows users to display a bar graph of the selected peak(s) as described above. 
The code for the SVM classifier is fairly similar to that of the Tree classifier. The primary 
difference is that the sequentialfs method uses the methods svmtrain and svmclassifiy to produce 
a score for the feature. Based on this score, sequentialfs decides whether the feature is kept or 
removed. 
WEKA SVM Classifier 
 Support vector machine using sequential minimal optimization (SMO) technique. 
 Uses training and test sets. If no test set is given, the training will be cross validated. 
 The number of folds for the cross validation is specified by the user. 
 If a test data set is not supplied, a dialog box is displayed with information about the 
classifier’s performance, including a confusion matrix. If a test set is supplied, then a 
summary of the accuracy percentages for each of the samples in the test set is displayed. 
Pseudocode: If a test set is supplied the program preforms the following: 
  Load the two files and convert their structures to a .ARFF format 
  Extract the data and set the class indices 
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  Instantiate the WEKA classifier  
  Build the classifier based on the training set 
  For each instance in the test set 
    classify the nth instance (this returns a label) 
    compare the label from the above line and the real label 
  end 
  Calculate the accuracy and display a summary dialog 
If a test set is not supplied the program performs the following: 
Instantiate an instance of Evaluation with the training set 
Call the crossValidateModel function of the instance of Evaluation with 
the following arguments: 
    the type of classifier (SMO in this case) 
    the training set 
    the number of folds for the cross validation 
    the options for the classifier 
    a pseudo-random seed 
Display the results in a dialog window 
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WEKA SVM Attribute Selector 
 Support vector machine using sequential minimal optimization (SMO) technique. 
 The number folds for cross validation and attributes to select are specified by the user. 
 Accepts one file to use as a training data set. 
 Displays a dialog box with information about the selected attributes. 
Load the file and convert its structure to a .ARFF format     
Extract the data and set the class index 
Instantiate an instance of AttributeSelection, SVMAttributeEval, and 
Ranker 
Set the evaluator of the AttributeSelection as the SVMAttributeEval and 
the search as the Ranker  
Run the attribute selection 
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APPENDIX B.  PEAK ALIGNMENT VALIDATION 
Peak Alignment v2.0 (MeDDL Modification) 
 
 Below are typical landmark volatile peaks observed in male murine urine: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average Mass Average Time Compound ID 
(57) 7.92-8.51 3-heptanone 
(60), 115, 128 14.72-15.32 2-sec-butyl-4,5-dihydrothiazole [SBT] 
(71),41,93,121 16.97-17.72 linalool 
 
 Top figure is EI spectra for SBT 
 Below is diagram defining a unique 2-way match used in MeDDL for alignment 
 Registration windows (time and m/z) are defined in peak.ini by user prior to registration 
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Example Study Details: 
Date range of raw files: 1/20/2011 – 10/4/2011 
N=151  
 
Exposure group date of analysis: 
 FT1  1/20/2011 
 BP1  1/31/2011 
 BM2 2/16/2011 
 BP2 2/23/2011 
 YP2  8/6/2011 
 CTR1 8/24/2011 
 BA2 9/11/201 
 BA3 10/1/2011 
 
Experimental Time Shift: 
To accurately register this study, taking into account the 9 month length of analysis, it is 
necessary to determine time and mass variation of a subset of the above landmark peaks in 
murine urine. Samples from the C (48hr) timepoint will be used as these are present in each 
exposure group tested. 
 
Samples used for peak landmark comparison: 
FT1_DBA_17_C 
BP1_DBA_25_C  
BM2_DBA_41_C 
BP2_DBA_49_C 
YP2_DBA_57_C 
CTR1_DBA_65_C 
BA2_DBA_73_C 
BA3_DBA_81_C 
 
  
165 
 
3-Heptanone 
 
 
Current registration settings/algorithm not accurately capturing and registering peak (see 
below scatterplot).  
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Linalool 
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Delta-T Histogram approach: Calculation of chromatographic region/binned (delta T – 
Chromatographic time shift) histograms 
 Generate discrete histograms of the time deltas for misaligned peaks (comparing reference 
image to new candidate images) 
 Only unique, 2-way peak matches are utilized by MeDDL for generating alignment via 
polynomial fit.  
 Purpose of new function is to down-select identified unique two-way matches for 
generation of accurate curve for polynomial fit capable of aligning significant time shifts 
observed. 
 Utilized both static and dynamic deltaT bin sizes (in number of peaks and time windows) 
 Initially considered discarding first few minutes due to compounds eluting irrespective of 
column properties (bimodal deltaT distribution noted). 
 DeltaT histograms demonstrated logarithmic increase in time shift over chromatographic 
time (NOT linear) 
 Resulting alignment correction (polyfit) using deltaT distributions limited to third order 
polynomial as this showed best results  
 
Below are two examples of the misalignment from different time regions: 
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Generated DeltaT histograms, static 2 minute time window: 
2 Sample histogram alignment example: 
 
 
  
49C
73C
RT: 6.54 - 9.35
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Time (min)
0
10
20
30
40
50
60
70
80
90
100
0
10
20
30
40
50
60
70
80
90
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
6.61
8.51
9.09
6.87
8.68 8.918.727.957.77 8.807.436.71 9.17 9.247.04 7.727.13 7.21 7.25 7.63 7.877.48 8.198.05 8.32 8.39
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8.33 8.46 9.158.017.247.13 9.178.107.286.82 9.288.16 8.566.84 8.72 8.887.39 7.60 8.928.806.78 7.486.896.62 7.65 9.047.73
NL:
1.13E7
m/z= 
56.50-
57.50  MS 
BP2_DBA_
49_C
NL:
6.90E5
m/z= 
56.50-
57.50  MS 
ba2_dba_7
3_c
pk188
Pk923
pk907
pk186
pk911
pk920
pk175
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X = 22.88
Y = 23.46
Optimization of number of bins per histogram would be required. 10 appears to provide 
adequate resolution for this example.  
 
10 bins / 0.58 / matches with observed shift   15 bins / 0.6 
 
    
8 bins 0.64    Correlation of unique 2 way matches (i.e. 22.8 / 23.46)  
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Static 5 minute window: 
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data 1
   quadratic
   cubic
 To attempt to increase accuracy in polyfit and reduce bias in generated deltaT bins due to 
the peak density, bin sizes were next evaluated dynamically.  
 The bin time window increased using defined steps until a bin minimum peak count is 
achieved (both parameters user specified in the peak.ini). 
 
[HistStep PeaksPerHist] 
0.01 10 
 
 Below figures show example of dynamic bins and resulting corrective polynomials/residuals.  
 Note that in the 0-2.6 min window, a single cluster of 20 peaks exceeds the 10 peak 
threshold for bin creation.  
 This is due to the “hard ionization” EI method utilized causing a large number of fragment 
peaks generated for a single compound (example below) 
 Thus a single bin step can incorporate this molecular “bundle”, and induce the bias/bimodal 
distributions noted in the deltaT histograms. 
  
 
 
 
 
 Therefore, for GC/MS by EI, we MUST utilize a variant of our time binning filter algorithm in 
the down-selection of unique two way matching peaks to be used for polynomial fitting as 
the EI fragmentation patterns too heavily weight individual molecular peaks. 
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d:\data\...\raw files\bp2_dba_49_c 2/25/2011 1:48:06 PM Mouse#49
urine
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data 1
   cubic
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Time Binned Down Selection of Unique Two Way Matches: 
 Utilizes a modification of the time-bin algorithm originally created as a filter for EI spectra 
differential profiling described as follows: a supplementary time-binned, fold change 
algorithm which was labeled as “hard ionization”. In the “hard ionization” method, the 
analyst specified both a time window and peak intensity threshold for comparison. The 
comparison then proceeded as follows: an averaged composite image of each user-defined 
comparative group was generated; the most intense peak from all comparative groups was 
evaluated across all aligned images using criteria specified; once the comparison was 
completed, this “time slice” based upon the peak apex ± ½ of the specified time window is 
removed from further analysis and the next most intense set of peaks are compared. 
 Application of time binning in the matched peak set allows for the logical and 
chromatographically distributed down-selection of the most predominant (intense) unique 
two-way matching peaks and avoids the weighting issues observed in deltaT binning (artifact 
of EI). 
 This algorithm may be turned on/off and the time window parameter specified by the user 
prior to registration in the peak.ini (below). 
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Intensity Unaligned Time Matched Time
Pk74 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 155 43.9281 1.63E+07 1.3185 1.3105 43.9268 23593
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 147 43.9502 1828209 1.2524 1.4042 43.9489 8690
Pk7 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 161 58.0244 2.29E+07 1.3685 1.3604 58.0234 24580
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 164 58.0181 2732492 1.3932 1.5575 58.0148 9858
Pk57 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 216 42.9806 2.63E+07 1.8245 1.8159 42.9793 33562
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 202 42.9901 2289576 1.7083 1.8995 42.9891 12836
Pk559 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 228 206.9607 2.26E+07 1.924 1.9153 206.9314 35821
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 211 206.9519 2583981 1.7828 1.9802 207.0146 13847
Pk287 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 272 71.9965 9676288 2.2885 2.2796 71.9952 44684
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 253 72.0009 215830 2.1313 2.357 71.9969 19575
Pk893 1
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 286 56.0603 291657 2.4047 2.3956 56.0593 47465
2
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 263 56.0837 52237 2.2141 2.4463 56.0806 -20800
RT: 0.97 - 3.06
1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8 3.0
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1.781.39
1.71
2.94
1.25 2.21 2.852.13
2.65
1.18
2.291.921.37 1.82
1.32
2.552.402.10
1.48 1.731.211.00
NL:
1.58E8
TIC  MS 
BA2_DBA_
73_C
NL:
1.08E9
TIC  MS 
bp2_dba_4
9_c
Time Binning 2 Sample Validation: 
 2 Sample Validation: Approximate 0.6min shift easily observed.  
 Note that previous images show linear fitting inadequate for proper alignment. 
 Binning studies show that this shift increased rapidly in the first 4 minutes. 
 Due to observed behavior, alignment of the first few chromatographic minutes likely most 
problematic 
 No significant peaks observed after 37 minutes 
       
        
Example registered peak table used for verification: 
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RT: 0.00 - 80.03
0 10 20 30 40 50 60 70 80
Time (min)
0
50
100
0
50
100
0
50
100
0
50
100
0
50
100
R
e
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ti
v
e
 A
b
u
n
d
a
n
c
e
0
50
100
0
50
100
0
50
100
2.69
13.95
4.83 15.32
11.99 23.47 30.60 36.49 43.39 47.45 53.52 71.5966.72
2.69
13.95
4.82 15.32
19.95 30.60 36.48 39.37 46.84 52.17 63.67 73.56
13.962.68
15.33
4.82
6.60 19.96 23.47 30.60 36.48 43.44 47.66 52.99 65.27 68.61
2.69
13.94 15.34
4.83
11.99 16.91 23.47 30.60 36.49 40.40 45.98 70.5951.85 65.92 78.85
2.45
13.32 14.72
4.36
6.02 16.34 30.0222.89 32.50 42.76 72.2266.1559.6747.03
2.45
13.32 14.724.35
22.88 30.02 34.85 42.41 78.6646.10 72.3368.2159.45
2.45
14.7213.32
11.43 19.38 22.88 30.02 35.85 42.63 46.08 76.1759.76 66.05
2.45
14.73
4.37
6.03 19.38 22.89 30.02 35.85 42.32 46.57 72.3464.4760.50
NL:
1.00E9
TIC  MS 
bp2_c57_53
_c
NL:
1.08E9
TIC  MS 
bp2_dba_49
_c
NL:
7.26E8
TIC  MS 
bp2_dba_50
_c
NL:
9.36E8
TIC  MS 
bp2_dba_52
_c
NL:
1.84E8
TIC  MS 
ba2_c57_78
_c
NL:
1.80E8
TIC  MS 
ba2_c57_79
_c
NL:
1.58E8
TIC  MS 
ba2_dba_73
_c
NL:
2.17E8
TIC  MS 
ba2_dba_74
_c
d:\data\...\multitest\bp2_c57_53_c 2/25/2011 8:24:44 PM Mouse#53
urine
RT: 0.00 - 80.03
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13.94
15.34
36.49 40.40 45.98 70.5954.80 65.92 78.85
13.32
4.36
11.42
16.34
27.02
13.32
9.15
16.35
14.72
35.8525.09 42.63 45.63 76.1759.76 66.05
2.45
14.73
NL:
1.00E9
TIC  MS 
bp2_c57_53
_c
NL:
1.08E9
TIC  MS 
bp2_dba_49
_c
NL:
7.26E8
TIC  MS 
bp2_dba_50
_c
NL:
9.36E8
TIC  MS 
bp2_dba_52
_c
NL:
1.84E8
TIC  MS 
ba2_c57_78
_c
NL:
1.80E8
TIC  MS 
ba2_c57_79
_c
NL:
1.58E8
TIC  MS 
ba2_dba_73
_c
NL:
2.17E8
TIC  MS 
ba2_dba_74
_c
Time Binning 8 Sample Validation: 
 Subset of sample validated: Limited to 8 by Thermo Xcalibur in number of spectral overlays 
possible 
 Shifts similar to 2 sample validation 
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 The 0-4 minute time range arguably best illustrates the power of this method for EI GC/MS 
alignment (note peaks at 1.37 and 1.82 minutes). 
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 Please note response of pk437 and pk1892 (4.82 min).  
 
 Registration of the leading shoulder can be eliminated through the time binning filter with a 
0.1 min window (verified) 
 Not artifact, as new registration algorithm only down-selects 2 way matches used for 
alignment and does not affect peak detection. 
 
  
Pk437 1
BP2_C57_
53_C
2011 02 
25 BP C57 53 48 A_UNSTR 577 125.9954 4.73E+07 4.8172 4.7937 125.9941 115595
2
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 577 125.9956 5.11E+07 4.8172 4.7985 125.9939 110748
3
BP2_DBA
_50_C
2011 02 
25 BP DBA 50 48 A_UNSTR 577 125.9974 3.13E+07 4.8172 4.7972 125.9935 114649
4
BP2_DBA
_52_C
2011 02 
25 BP DBA 52 48 A_UNSTR 578 126.0016 4.38E+07 4.8253 4.802 126.0033 116725
5
BA2_C57
_78_C
2011 09 
13 BA C57 78 48 A_UNSTR 521 125.9819 6808069 4.3529 4.7263 125.9872 65118
6
BA2_C57
_79_C
2011 09 
13 BA C57 79 48 A_UNSTR 521 126.0349 6433989 4.3529 4.7304 126.0305 64539
7
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 521 125.983 6293168 4.3529 4.7294 125.9796 57477
8
BA2_DBA
_74_C
2011 09 
13 BA DBA 74 48 A_UNSTR 523 125.9842 8536832 4.3695 4.7415 125.9808 -65652
Pk1892 1
BP2_C57_
53_C
2011 02 
25 BP C57 53 48 A_UNSTR 577 125.9954 4.73E+07 4.8172 4.7937 125.9941 -115595
2
BP2_DBA
_49_C
2011 02 
25 BP DBA 49 48 A_UNSTR 554 126.0493 103342 4.6266 4.6088 126.0476 105737
3
BP2_DBA
_50_C
2011 02 
25 BP DBA 50 48 A_UNSTR 580 125.0734 95976 4.8422 4.822 125.0694 115301
4
BP2_DBA
_52_C
2011 02 
25 BP DBA 52 48 A_UNSTR 577 126.0429 4.23E+07 4.8172 4.794 126.0446 -116493
5
BA2_C57
_78_C
2011 09 
13 BA C57 78 48 A_UNSTR 521 125.9819 6808069 4.3529 4.7263 125.9872 -65118
6
BA2_C57
_79_C
2011 09 
13 BA C57 79 48 A_UNSTR 521 126.0349 6433989 4.3529 4.7304 126.0305 -64539
7
BA2_DBA
_73_C
2011 09 
13 BA DBA 73 48 A_UNSTR 521 125.983 6293168 4.3529 4.7294 125.9796 -57477
8
BA2_DBA
_74_C
2011 09 
13 BA DBA 74 48 A_UNSTR 523 125.9842 8536832 4.3695 4.7415 125.9808 -65652
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Peak Shoulder Registration: 
Increasing baseline to 300K absolute eliminates registration of shoulder peaks. 
 
Old registration parameters   New registration parameters  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resulted in 2422 peaks detected Resulted in 918 peaks detected 
[minIval]    [minIval] 
25000     100000 
[HotPeakTH]    [HotPeakTH] 
50000     300000 
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Additional manual examination of right combined spectra demonstrate that use of above 
peak.ini parameters resulted in no missed significant peaks and no duplicate registration of 
leading/tailing edges. 
 
Conclusion: no overlap in peak registration (shoulders) for same mass seen when baseline 
increased to 300K absolute. 
  
D:\Data\...\MultiTest\BP2_C57_53_C 2/25/2011 8:24:44 PM Mouse#53
urine
RT: 1.20 - 5.55
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1.92
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2.30
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5.07
3.10
3.50
2.40
1.48
4.154.00 4.25
2.29
1.92
1.82
3.10
3.23
5.07
2.55
3.49 4.00
4.41
2.30
5.30
3.23
5.07
2.40
3.13
3.49
1.48
4.00
1.82
3.23
5.073.50
4.80
2.13
1.25 4.602.94
1.45
3.593.10
5.01
5.24
1.71
2.13
4.60 4.80
3.59
1.78
1.39
1.71
2.21
2.852.13 4.79
1.78
1.40
1.72
2.95
2.85
3.22
NL:
1.00E9
TIC  MS 
BP2_C57_53
_C
NL:
1.08E9
TIC  MS 
bp2_dba_49
_c
NL:
7.05E8
TIC  MS 
bp2_dba_50
_c
NL:
9.36E8
TIC  MS 
bp2_dba_52
_c
NL:
1.84E8
TIC  MS 
ba2_c57_78
_c
NL:
1.80E8
TIC  MS 
ba2_c57_79
_c
NL:
1.58E8
TIC  MS 
ba2_dba_73
_c
NL:
2.17E8
TIC  MS 
ba2_dba_74
_c
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APPENDIX C.  PEAK NORMALIZATION 
Normalization Test (8 Sample) 
 
Purpose: To evaluate the effect of normalization on stress study data (8 sample example) 
 
Example Study Details: 
Date range of raw files: 1/20/2011 – 10/4/2011 
N=151  
 
Exposure group date of analysis: 
 FT1  1/20/2011 
 BP1  1/31/2011 
 BM2 2/16/2011 
 BP2 2/23/2011 
 YP2  8/6/2011 
 CTR1 8/24/2011 
 BA2 9/11/201 
 BA3 10/1/2011 
 
Decreased Sensitivity: 
To accurately analyze this study, normalization of some type is required. Following the 6 month 
down-time of Feb – Aug, a significant decrease in sensitivity was noted.  Samples from the C 
(48hr) timepoint will be used for validation as these are present in each exposure group tested. 
 
Samples used for peak landmark comparison: 
FT1_DBA_17_C 
BP1_DBA_25_C  
BM2_DBA_41_C 
BP2_DBA_49_C 
YP2_DBA_57_C 
CTR1_DBA_65_C 
BA2_DBA_73_C 
BA3_DBA_81_C 
 
 
 
 
 
 
Group A 
Group B 
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Summary of major peaks: 
Numbers for UnNorm, TIC Norm, and Olympic represent the relative fold change between 
analysis time groups (A/B) referenced above. 
 
R.T. Peak 
UnNorm 
TIC 
Norm Olympic 
2.7 126 5.51 1.09 1.15 
4.78 152 6.18 1.03 1.02 
6.54 153 6.3 1.04 1.02 
13.93 141 6.56 1.11 1.06 
15.32 60 4.57 1.29 1.35 
19.95 131 5.31 1.1 1.13 
Olympic used 80/20% 
 
 
 
  
RT: 0.00 - 80.03
0 10 20 30 40 50 60 70 80
Time (min)
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100
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100
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A
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0
50
100
0
50
100
0
50
100
2.69
13.95
4.83 15.32
11.99 23.47 30.60 36.49 43.39 47.45 53.52 71.5966.72
2.69
13.95
4.82 15.32
19.95 30.60 36.48 39.37 46.84 52.17 63.67 73.56
13.962.68
15.33
4.82
6.60 19.96 23.47 30.60 36.48 43.44 47.66 52.99 65.27 68.61
2.69
13.94 15.34
4.83
11.99 16.91 23.47 30.60 36.49 40.40 45.98 70.5951.85 65.92 78.85
2.45
13.32 14.72
4.36
6.02 16.34 30.0222.89 32.50 42.76 72.2266.1559.6747.03
2.45
13.32 14.724.35
22.88 30.02 34.85 42.41 78.6646.10 72.3368.2159.45
2.45
14.7213.32
11.43 19.38 22.88 30.02 35.85 42.63 46.08 76.1759.76 66.05
2.45
14.73
4.37
6.03 19.38 22.89 30.02 35.85 42.32 46.57 72.3464.4760.50
NL:
1.00E9
TIC  MS 
bp2_c57_53
_c
NL:
1.08E9
TIC  MS 
bp2_dba_49
_c
NL:
7.26E8
TIC  MS 
bp2_dba_50
_c
NL:
9.36E8
TIC  MS 
bp2_dba_52
_c
NL:
1.84E8
TIC  MS 
ba2_c57_78
_c
NL:
1.80E8
TIC  MS 
ba2_c57_79
_c
NL:
1.58E8
TIC  MS 
ba2_dba_73
_c
NL:
2.17E8
TIC  MS 
ba2_dba_74
_c
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